<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">36234</article-id><article-id pub-id-type="doi">10.7554/eLife.36234</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Sex-dependent effects of in utero cannabinoid exposure on cortical function</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes" id="author-108553"><name><surname>Bara</surname><given-names>Anissa</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-108554"><name><surname>Manduca</surname><given-names>Antonia</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-108555"><name><surname>Bernabeu</surname><given-names>Axel</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-108556"><name><surname>Borsoi</surname><given-names>Milene</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-108557"><name><surname>Serviado</surname><given-names>Michela</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-108558"><name><surname>Lassalle</surname><given-names>Olivier</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-108565"><name><surname>Murphy</surname><given-names>Michelle</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-108566"><name><surname>Wager-Miller</surname><given-names>Jim</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-44834"><name><surname>Mackie</surname><given-names>Ken</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-8501-6199</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-108561"><name><surname>Pelissier-Alicot</surname><given-names>Anne-Laure</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-108562"><name><surname>Trezza</surname><given-names>Viviana</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-36292"><name><surname>Manzoni</surname><given-names>Olivier J</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-5579-6208</contrib-id><email>olivier.manzoni@inserm.fr</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf2"/></contrib><aff id="aff1"><label>1</label><institution>Aix Marseille University, INSERM, INMED</institution><addr-line><named-content content-type="city">Marseille</named-content></addr-line><country>France</country></aff><aff id="aff2"><label>2</label><institution content-type="dept">Cannalab, Cannabinoids Neuroscience Research International Associated Laboratory</institution><institution>Indiana University</institution><addr-line><named-content content-type="city">Indiana</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution content-type="dept">Section of Biomedical Sciences and Technologies, Department of Science</institution><institution>University Roma Tre</institution><addr-line><named-content content-type="city">Rome</named-content></addr-line><country>Italy</country></aff><aff id="aff4"><label>4</label><institution content-type="dept">APHM</institution><institution>CHU Conception, Service de Psychiatrie</institution><addr-line><named-content content-type="city">Marseille</named-content></addr-line><country>France</country></aff><aff id="aff5"><label>5</label><institution content-type="dept">Department of Psychological and Brain Sciences</institution><institution>Indiana University</institution><addr-line><named-content content-type="city">Bloomington</named-content></addr-line><country>United States</country></aff><aff id="aff6"><label>6</label><institution content-type="dept">Gill Centre</institution><institution>Indiana University</institution><addr-line><named-content content-type="city">Bloomington</named-content></addr-line><country>United States</country></aff><aff id="aff7"><label>7</label><institution content-type="dept">APHM</institution><institution>CHU Timone Adultes, Service de Médecine Légale</institution><addr-line><named-content content-type="city">Marseille</named-content></addr-line><country>France</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Kauer</surname><given-names>Julie A</given-names></name><role>Reviewing Editor</role><aff><institution>Brown University</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Dulac</surname><given-names>Catherine</given-names></name><role>Senior Editor</role><aff><institution>Harvard University</institution><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date date-type="publication" publication-format="electronic"><day>11</day><month>09</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>7</volume><elocation-id>e36234</elocation-id><history><date date-type="received" iso-8601-date="2018-02-26"><day>26</day><month>02</month><year>2018</year></date><date date-type="accepted" iso-8601-date="2018-08-15"><day>15</day><month>08</month><year>2018</year></date></history><permissions><copyright-statement>© 2018, Bara et al</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Bara et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-36234-v2.pdf"/><related-article ext-link-type="doi" id="ra1" related-article-type="commentary" xlink:href="10.7554/eLife.41229"/><abstract><object-id pub-id-type="doi">10.7554/eLife.36234.001</object-id><p>Cannabinoids can cross the placenta, thus may interfere with fetal endocannabinoid signaling during neurodevelopment, causing long-lasting deficits. Despite increasing reports of cannabis consumption during pregnancy, the protracted consequences of prenatal cannabinoid exposure (PCE) remain incompletely understood. Here, we report sex-specific differences in behavioral and neuronal deficits in the adult progeny of rat dams exposed to low doses of cannabinoids during gestation. In males, PCE reduced social interaction, ablated endocannabinoid long-term depression (LTD) and heightened excitability of prefrontal cortex pyramidal neurons, while females were spared. Group 1 mGluR and endocannabinoid signaling regulate emotional behavior and synaptic plasticity. Notably, sex-differences following PCE included levels of mGluR1/5 and TRPV1R mRNA. Finally, positive allosteric modulation of mGlu5 and enhancement of anandamide levels restored LTD and social interaction in PCE adult males. Together, these results highlight marked sexual differences in the effects of PCE and introduce strategies for reversing detrimental effects of PCE.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>cannabis</kwd><kwd>in-utero</kwd><kwd>sex difference</kwd><kwd>social behavior</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Rat</kwd></kwd-group><funding-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003593</institution-id><institution>Conselho Nacional de Desenvolvimento Científico e Tecnológico</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Borsoi</surname><given-names>Milene</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001665</institution-id><institution>Agence Nationale de la Recherche</institution></institution-wrap></funding-source><award-id>Cannado</award-id><principal-award-recipient><name><surname>Bara</surname><given-names>Anissa</given-names></name><name><surname>Pelissier-Alicot</surname><given-names>Anne-Laure</given-names></name><name><surname>Manzoni</surname><given-names>Olivier J</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002915</institution-id><institution>Fondation pour la Recherche Médicale</institution></institution-wrap></funding-source><award-id>Equipe FRM 2015</award-id><principal-award-recipient><name><surname>Bara</surname><given-names>Anissa</given-names></name><name><surname>Borsoi</surname><given-names>Milene</given-names></name><name><surname>Manzoni</surname><given-names>Olivier J</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>5R01DA043982-02</award-id><principal-award-recipient><name><surname>Mackie</surname><given-names>Ken</given-names></name><name><surname>Manzoni</surname><given-names>Olivier J</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Adult male, but not female, rats showed altered neuronal function, inhibited synaptic plasticity and diminished social behavior following cannabinoid exposure during gestation in a model of cannabis use during pregnancy.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>With 181.8 million estimated regular users aged 15 – 64, cannabis is the most commonly consumed illicit drug around the world (UNODC, 2015). The majority of users are young, and exposure largely occurs during their reproductive years (SAMSHA, 2015). In fact, data collected from 2002 to 2014 in the U.S. indicates that 7.5% of pregnant women between 18 and 25 years of age use cannabis, while the rate of use in all pregnant women is approximately 4% (<xref ref-type="bibr" rid="bib8">Brown et al., 2017</xref>). A longitudinal prospective study on drug use in pregnancy showed that 48% of women who used cannabis in the year prior to their pregnancy continued to smoke cannabis throughout pregnancy (<xref ref-type="bibr" rid="bib62">Moore et al., 2010</xref>). Moreover, 70% of pregnant and non-pregnant women believe that there is little or no harm in using cannabis once or twice per week (<xref ref-type="bibr" rid="bib40">Ko et al., 2015</xref>). Thus, cannabis consumption during pregnancy is a major public health concern worthy of study as thousands of infants are prenatally exposed to cannabis.</p><p>Worldwide legalization and/or decriminalization initiatives emphasize the urgent need for scientific evidence regarding possible harms and benefits of cannabis use. Epidemiological studies of children with a history of in utero cannabis exposure reveal normal intelligence scores but altered cognition and executive functions (attention, memory, concentration, inhibitory control) and higher levels of depression and anxiety during adolescence (<xref ref-type="bibr" rid="bib24">Grant et al., 2018</xref>; <xref ref-type="bibr" rid="bib29">Higuera-Matas et al., 2015</xref>) have been reported. In animal studies, prenatal exposure to various regimens of cannabinoids has been linked to alterations in locomotor, learning, memory, emotional functions and social interaction (<xref ref-type="bibr" rid="bib9">Campolongo et al., 2011</xref>; <xref ref-type="bibr" rid="bib29">Higuera-Matas et al., 2015</xref>; <xref ref-type="bibr" rid="bib80">Vargish et al., 2017</xref>). A major caveat is that most studies investigated effects using male progeny only.</p><p>Δ9-Tetrahydrocannabinol (THC), the major psychoactive ingredient in marijuana and other cannabis-based preparations, efficiently crosses the placental barrier and reaches the fetus (<xref ref-type="bibr" rid="bib30">Hurd et al., 2005</xref>; <xref ref-type="bibr" rid="bib31">Hutchings et al., 1989</xref>). In the brain, cannabinoid receptor type 1 (CB1R) is the main target of THC. The endocannabinoid system, mainly through CB1R, has been implicated in neuronal proliferation, migration, morphogenesis and synaptogenesis (<xref ref-type="bibr" rid="bib6">Berghuis et al., 2007</xref>; <xref ref-type="bibr" rid="bib28">Harkany et al., 2007</xref>; <xref ref-type="bibr" rid="bib47">Maccarrone et al., 2014</xref>; <xref ref-type="bibr" rid="bib63">Mulder et al., 2008</xref>). Consequently, it is crucial to understand the long-term consequences of cannabinoid exposure at this critical stage of development in both sexes.</p><p>Here, we examined how prenatal cannabinoid exposure (PCE) (to synthetic and plant-derived cannabinoids) influences the synaptic and behavioral functions of the medial prefrontal cortex, a brain region implicated in neuropsychiatric disorders. We observed marked sexual divergence in the protracted effects of PCE. Following PCE, social interaction was altered in adult male rats and this alteration was paralleled by sex-specific deficits in synaptic plasticity, neuronal excitability and relevant mRNA levels in the mPFC. We discovered that pharmacological potentiation of mGlu<sub>5</sub> or blockade of anandamide degradation both normalized behavioral and synaptic deficits. The data reveal new endophenotypes of PCE and identify new therapeutic strategies.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Sex differences in the behavioral effects of prenatal cannabinoid exposure in the adult progeny</title><p>In rodent models, the consumption of synthetic or plant-derived cannabinoids during gestation has multiple deleterious consequences on the progeny’s behavior (reviewed in <xref ref-type="bibr" rid="bib9">Campolongo et al., 2011</xref>; <xref ref-type="bibr" rid="bib29">Higuera-Matas et al., 2015</xref>; <xref ref-type="bibr" rid="bib80">Vargish et al., 2017</xref>). In these earlier studies, different drug and treatment regimen were used and multiple behaviors studied in the progeny at various ages. Here, to simplify the analysis/maximize the significance of our comparisons of molecular, synaptic and behavioral measures we first decided to generate a coherent new dataset. Thus, gestating dams were exposed a single daily low dose of the synthetic cannabinoid WIN55,212 – 2 (WIN, 0.5 mg/kg, s.c. or vehicle or SHAM) between GD5 and GD20. Key findings were reproduced with the phytocannabinoid Δ9-Tetrahydrocannabinol, THC (5 mg/kg). This protocol of PCE is clinically relevant, since the doses of WIN and THC used here correspond to a moderate exposure of cannabis in humans, correcting for the differences in route of administration and body weight surface area (<xref ref-type="bibr" rid="bib20">Garcia et al., 1998</xref>; <xref ref-type="bibr" rid="bib61">Mereu et al., 2003</xref>). We compared male and female SHAM and cannabinoid-exposed progeny in a series of behavioral tests to explore social behavior, anxiety, locomotion and cognition at the adult stage (PND &gt;90). In accord with international ethical guidelines to reduce the number of animal used and their treatment/manipulations, once we had established that there was no difference between sham and naive animals (<xref ref-type="table" rid="table2"><xref ref-type="table" rid="table1">Table 1</xref></xref>), data from animals in both groups were pooled and naive rat dams were included in the SHAM group.</p><table-wrap id="table1" position="float"><object-id pub-id-type="doi">10.7554/eLife.36234.002</object-id><label>Table 1.</label><caption><title>Statistical significance of different behavioral tasks in SHAM and Naive animals.</title><p>Prenatal treatment from GD 5 to GD 20 with vehicle solution in control dams (SHAM group) did not alter sociability (social interaction), anxiety (elevated plus maze), and cognition (temporal order and object recognition memory tasks) in adult rats of either sex. Statistical significance was determined using the unpaired Student’s t-test after outliers were detected and removed from the dataset using Grubbs’ test.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top">Behavior</th><th valign="top">Parameter</th><th valign="top">Treatment</th><th valign="top">Sex</th><th valign="top">n</th><th valign="top">Mean</th><th valign="top">SEM</th><th valign="top">P <break/>value (Unpaired <break/>t test)</th></tr></thead><tbody><tr><td rowspan="4" valign="top">Social Interaction</td><td rowspan="4" valign="top"># of contacts</td><td valign="top">NAIVE</td><td rowspan="2" valign="top">Male</td><td valign="top">5</td><td valign="top">216.200</td><td valign="top">28.420</td><td rowspan="2" valign="top">0.439</td></tr><tr><td valign="top">SHAM</td><td valign="top">10</td><td valign="top">235.800</td><td valign="top">10.550</td></tr><tr><td valign="top">NAIVE</td><td rowspan="2" valign="top">Female</td><td valign="top">4</td><td valign="top">211.800</td><td valign="top">21.600</td><td rowspan="2" valign="top">0.85</td></tr><tr><td valign="top">SHAM</td><td valign="top">7</td><td valign="top">215.100</td><td valign="top">5.713</td></tr><tr><td rowspan="8" valign="top">Elevated Plus Maze</td><td rowspan="4" valign="top">% Time Open</td><td valign="top">NAIVE</td><td rowspan="2" valign="top">Male</td><td valign="top">6</td><td valign="top">25.900</td><td valign="top">2.988</td><td rowspan="2" valign="top">0.665</td></tr><tr><td valign="top">SHAM</td><td valign="top">7</td><td valign="top">24.270</td><td valign="top">2.245</td></tr><tr><td valign="top">NAIVE</td><td rowspan="2" valign="top">Female</td><td valign="top">9</td><td valign="top">25.530</td><td valign="top">2.464</td><td rowspan="2" valign="top">0.359</td></tr><tr><td valign="top">SHAM</td><td valign="top">9</td><td valign="top">22.540</td><td valign="top">1.978</td></tr><tr><td rowspan="4" valign="top">% Open Entries</td><td valign="top">NAIVE</td><td rowspan="2" valign="top">Male</td><td valign="top">6</td><td valign="top">27.740</td><td valign="top">3.248</td><td rowspan="2" valign="top">0.164</td></tr><tr><td valign="top">SHAM</td><td valign="top">7</td><td valign="top">33.950</td><td valign="top">2.678</td></tr><tr><td valign="top">NAIVE</td><td rowspan="2" valign="top">Female</td><td valign="top">9</td><td valign="top">33.160</td><td valign="top">2.520</td><td rowspan="2" valign="top">0.475</td></tr><tr><td valign="top">SHAM</td><td valign="top">9</td><td valign="top">30.230</td><td valign="top">3.111</td></tr><tr><td rowspan="4" valign="top">Temporal order</td><td rowspan="4" valign="top">Discrimination index</td><td valign="top">NAIVE</td><td rowspan="2" valign="top">Male</td><td valign="top">8</td><td valign="top">0.320</td><td valign="top">0.085</td><td rowspan="2" valign="top">0.702</td></tr><tr><td valign="top">SHAM</td><td valign="top">7</td><td valign="top">0.366</td><td valign="top">0.078</td></tr><tr><td valign="top">NAIVE</td><td rowspan="2" valign="top">Female</td><td valign="top">8</td><td valign="top">0.258</td><td valign="top">0.132</td><td rowspan="2" valign="top">0.896</td></tr><tr><td valign="top">SHAM</td><td valign="top">7</td><td valign="top">0.277</td><td valign="top">0.038</td></tr><tr><td rowspan="4" valign="top">Object Recognition</td><td rowspan="4" valign="top">Discrimination Index</td><td valign="top">NAIVE</td><td rowspan="2" valign="top">Male</td><td valign="top">10</td><td valign="top">0.547</td><td valign="top">0.087</td><td rowspan="2" valign="top">0.792</td></tr><tr><td valign="top">SHAM</td><td valign="top">8</td><td valign="top">0.580</td><td valign="top">0.086</td></tr><tr><td valign="top">NAIVE</td><td rowspan="2" valign="top">Female</td><td valign="top">7</td><td valign="top">0.323</td><td valign="top">0.126</td><td rowspan="2" valign="top">0.481</td></tr><tr><td valign="top">SHAM</td><td valign="top">7</td><td valign="top">0.421</td><td valign="top">0.045</td></tr></tbody></table></table-wrap><p>We found that PCE impaired specific components of social interactions in adult male rats. Thus, PCE males had less contact and spent less time interacting with their congeners than those exposed in-utero to vehicle (<xref ref-type="fig" rid="fig1">Figure 1A–B</xref>). Detailed exploration of the various parameters of social interaction revealed that sniffing (<xref ref-type="fig" rid="fig1">Figure 1C–D</xref>) and playing (<xref ref-type="fig" rid="fig1">Figure 1E</xref>) behaviors were impaired in PCE males while the number of attacks remained unchanged (<xref ref-type="fig" rid="fig1">Figure 1F</xref>). The low socialization in PCE males was unlikely due to impaired motor locomotion, as we found no significant change in the distance traveled between WIN and SHAM groups during testing (3758 ± 117.8 cm, n = 10; and 3779 ± 228.8 cm, n = 8; t<sub>(7)</sub> = 0.02, p&gt;0.05, t-test; SHAM- and WIN-exposed rats, respectively).</p><fig-group><fig id="fig1" position="float"><object-id pub-id-type="doi">10.7554/eLife.36234.003</object-id><label>Figure 1.</label><caption><title>Prenatal cannabinoid exposure induces sex-specific social deficits at adulthood.</title><p>(<bold>A–B</bold>) Adult male progeny from dams exposed during gestation to WIN had less contact (<bold>A</bold>): F<sub>(sex x treat)1,28</sub>=15.54, p&lt;0.05, two-way ANOVA) and spent less time interacting with their congeners than SHAM-animals (<bold>B</bold>): F<sub>(sex x treat)1,28</sub>=7.09, p&lt;0.05, two-way ANOVA). In contrast, the social behavior of female littermates was normal. During the social session, the number (<bold>C</bold>): F<sub>(sex x treat)1,28</sub>=16.30, p&lt;0.05, two-way ANOVA) and the time (<bold>D</bold>): F<sub>(sex x treat)1,28</sub>=14.87, p&lt;0.05, two-way ANOVA) of sniffing events and the frequency of play behavior (<bold>E</bold>): F<sub>(sex x treat)1,28</sub>=3.217, p&gt;0.05, two-way ANOVA) were exclusively reduced in male rats exposed to WIN during gestation. Prenatal cannabinoid exposure did not induce aggressive behavior in adult rats (<bold>F</bold>): F<sub>(sex x treat)1,28</sub>=0.037, p&gt;0.05, two-way ANOVA). Scatter dot plot represents a pair of animals. Error bars indicate SEM. *p&lt;0.05. Student–Newman–Keuls test.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-36234-fig1-v2"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.36234.004</object-id><label>Figure 1—figure supplement 1.</label><caption><title>Social isolation before testing did not induce sex-specific social changes in adult animals.</title><p>(<bold>A-B</bold>) Adult male and female naïve animals not isolated 24 hr before testing showed no difference in contact (<bold>A</bold>): F<sub>(sex x isolation)1,29</sub>=0.203, p&gt;0.05, two-way ANOVA) and time to interact with their congeners than male and female SHAM-animals isolated before testing (<bold>B</bold>): F<sub>(sex x isolation)1,29</sub>=0.372, p&gt;0.05, two-way ANOVA). During the social session, the number (<bold>C</bold>): F<sub>(sex x isolation)1,29</sub>=0.003, p&gt;0.05, two-way ANOVA) and the time (<bold>D</bold>): F<sub>(sex x isolation)1,28</sub>=1.253, p&gt;0.05, two-way ANOVA) of sniffing events were unchanged; the frequency of play behavior (<bold>E</bold>): F<sub>(sex x isolation)1,29</sub>=1.289, p&gt;0.05, two-way ANOVA) were exclusively reduced in female naïve rats not isolated before testing. Social isolation did not change aggressive behavior in adult naïve rats (<bold>F</bold>): F<sub>(sex x isolation)1,29</sub>=0.325, p&gt;0.05, two-way ANOVA). Scatter dot plot represents a pair of animals. Error bars indicate SEM. *p&lt;0.05. Student–Newman–Keuls test.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-36234-fig1-figsupp1-v2"/></fig></fig-group><p>Interestingly, we discovered that the deleterious effects of PCE on social behavior were specific to male offspring. In PCE adult female rats, social behavior was indistinguishable from that of the SHAM group; there was no difference in the total frequency and time (<xref ref-type="fig" rid="fig1">Figure 1</xref>) of social interaction in either group.</p><p>Social behaviors require emotional control and cognitive abilities. To test for the generalization of PCE-induced deficits across these behavioral dimensions we estimated anxiety and cognition in our model. No differences between WIN- and SHAM prenatally-exposed rats were found in the elevated plus maze. Specifically, there was no change in the percentage of time spent in the open arms (<xref ref-type="fig" rid="fig2">Figure 2A</xref>), percentage of open arm entries (<xref ref-type="fig" rid="fig2">Figure 2B</xref>), in the time spent in the open and close arms (<xref ref-type="fig" rid="fig2">Figure 2C–D</xref>), number of closed-arm entries ([F<sub>(treat x sex)1,29</sub> = 0.195 p=0.662]; data not shown), stretch-attended posture ([F<sub>(treat x sex)1,29</sub> = 0.167 p=0.685]; data not shown) and frequency of head-dippings ([F<sub>(treat x sex)1,29</sub> = 0.338 p=0.565; data not shown).</p><fig id="fig2" position="float"><object-id pub-id-type="doi">10.7554/eLife.36234.005</object-id><label>Figure 2.</label><caption><title>Prenatal cannabinoid exposure does not modify adult cognitive and anxious behaviors in both sexes.</title><p>(<bold>A–B</bold>) Prenatal cannabinoid exposure did not alter anxiety behavior in adult rats of either sex. No differences between WIN-exposed and SHAM animals were found in the elevated plus maze test as expressed in the percentage of time spent in the open arms (<bold>A</bold>): F<sub>(treat x sex)1,29</sub>=0.818, p&gt;0.05, two-way ANOVA), the percentage of open arm entries (<bold>B</bold>): F<sub>(treat x sex)1,29</sub>=3.762, p&gt;0.05, two-way ANOVA), the time spent exploring the open (<bold>C</bold>): F<sub>(treat x sex)1,29</sub>=0.04, p&gt;0.05, two-way ANOVA) and the closed arm (<bold>D</bold>): F<sub>(treat x sex)1,29</sub>=0.944, p&gt;0.05, two-way ANOVA). (<bold>E–F</bold>), Prenatal cannabinoid exposure did not impair cognitive performance. (<bold>E–F</bold>), In the temporal order memory task, no differences were found in the discrimination index (<bold>E</bold>): F<sub>(treat x sex)1,25</sub>=0.549, p&gt;0.05, two-way ANOVA) and in the total time exploring objects during the test trial (<bold>F</bold>): F<sub>(treat x sex)1,25</sub>=0.001, p&gt;0.05, two-way ANOVA). (<bold>G–H</bold>) In the object recognition test, male and female rats exposed to the cannabinoid WIN in-utero showed no differences in their discrimination index (<bold>G</bold>): F<sub>(treat x sex)1,25</sub>=0.639, p&gt;0.05, two-way ANOVA) or the time exploring objects (<bold>H</bold>): F<sub>(treat x sex)1,25</sub>=0.04, p&gt;0.05, two-way ANOVA) from the SHAM group, suggesting no deficits in the recognition memory for objects. Scatter dot plot represents each animal. Error bars indicate SEM. *p&lt;0.05. Student–Newman–Keuls test.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-36234-fig2-v2"/></fig><p>Regarding their cognitive abilities, adult SHAM and WIN-exposed animals of both sexes displayed identical discrimination index and exploration time in both the temporal order memory task (<xref ref-type="fig" rid="fig2">Figure 2E–F</xref>) and the novel object recognition test (<xref ref-type="fig" rid="fig2">Figure 2G–H</xref>).</p><p>Thus, while social interaction was specifically impaired in PCE males, locomotion, anxiety and cognition were spared in both sexes. These data reveal discrete and sex-specific behavioral consequences of PCE at adulthood.</p></sec><sec id="s2-2"><title>Prenatal cannabinoid exposure alters synaptic plasticity specifically in the PFC of adult male</title><p>In theory, cannabinoid exposure during in-utero neurodevelopment may perturb synaptic functions in most brain areas. The finding of selective impairments of social interaction in the absence of emotional and cognitive deficits does not favor the hypothesis of widespread synaptic deficits. The prefrontal cortex and nucleus accumbens play prominent roles in social behaviors (<xref ref-type="bibr" rid="bib79">van Kerkhof et al., 2013</xref>) and prefronto-accumbens glutamatergic circuits modulate reward-related behaviors (<xref ref-type="bibr" rid="bib18">Floresco, 2015</xref>; <xref ref-type="bibr" rid="bib58">Mateo et al., 2017</xref>). Furthermore, the endogenous cannabinoid (eCB)-system of the accumbens core is instrumental to social interaction behavior (<xref ref-type="bibr" rid="bib49">Manduca et al., 2016</xref>; <xref ref-type="bibr" rid="bib78">Trezza et al., 2012</xref>). In-vivo cannabinoid exposure desensitizes CB1R and ablates eCB-mediated synaptic plasticity in the accumbens (<xref ref-type="bibr" rid="bib59">Mato et al., 2004</xref>; <xref ref-type="bibr" rid="bib60">Mato et al., 2005</xref>). Thus, we first compared eCB-mediated LTD (eCB-LTD) in our experimental groups. The data indicated that eCB-LTD in the accumbens is not affected by PCE (<xref ref-type="fig" rid="fig3">Figure 3</xref>).</p><fig id="fig3" position="float"><object-id pub-id-type="doi">10.7554/eLife.36234.006</object-id><label>Figure 3.</label><caption><title>Prenatal cannabinoid exposure does not modify LTD in NAc of adult rats.</title><p>(<bold>A</bold>) Average time-courses of mean fEPSPs showing that low-frequency stimulation (indicated by arrow) induces LTD at accumbens synapses in both SHAM- (white circles, n = 5) and WIN- (green circles, n = 5) exposed male rats. Above: example traces, baseline (1) and 40 min poststimulation (2). (<bold>B</bold>) Individual experiments (grey) and group average (tan), before (baseline) and after (40 min) LTD induction showing that PCE does not affect eCB-LTD in male accumbens. In SHAM male rats: 2.518 ± 0.145 mV.ms before LTD versus 1.872 ± 0.124 mV.ms after LTD induction (n = 5, p&lt;0.05, paired t-test). In WIN male: 2.152 ± 0.224 mV.ms before LTD versus 1.696 ± 0.073 mV.ms after LTD induction (n = 5, p&lt;0.05, paired t-test). (<bold>C</bold>) Average time-courses of mean EPSPs showing similar low-frequency LTD in SHAM (n = 6; white circles) and WIN (n = 4; orange circles) in utero-exposed female rats. Above: example traces, baseline (1) and 40 min poststimulation (2). (<bold>D</bold>) Individual experiments (grey) and group average (white represents SHAM; orange represents WIN), before (baseline) and after (40 min) LTD induction showing that prenatal WIN exposure does not alter LTD in the female exposed group. In SHAM female: 2.350 ± 0.191 mV.ms before LTD versus 1.800 ± 0.182 mV.ms after LTD induction (n = 6, p&lt;0.05, paired t-test). In WIN female: 2.461 ± 0.439 mV.ms before LTD versus 1.833 ± 0.381 mV.ms after LTD induction (n = 4, p&lt;0.05, paired t-test). n = individual rats. Error bars indicate SEM. Scale bar: 10 ms, 0.1 mV.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-36234-fig3-v2"/></fig><p>The extensive repertoire of synaptic plasticity displayed by medial prefrontal synapses is a consistent target of environmental and genetic insults (<xref ref-type="bibr" rid="bib32">Iafrati et al., 2014</xref>; <xref ref-type="bibr" rid="bib37">Kasanetz et al., 2013</xref>; <xref ref-type="bibr" rid="bib43">Labouesse et al., 2017</xref>; <xref ref-type="bibr" rid="bib45">Lafourcade et al., 2011</xref>; <xref ref-type="bibr" rid="bib50">Manduca et al., 2017</xref>; <xref ref-type="bibr" rid="bib75">Thomazeau et al., 2014</xref>). We first established that tetanic stimulation induced a robust eCB-LTD of excitatory synapses onto layer 5 mPFC pyramidal neurons in mPFC slices prepared from adult SHAM male and female rats (<xref ref-type="fig" rid="fig4">Figure 4A–B–C–D</xref>). In marked contrast to the accumbens, eCB-LTD in the mPFC was absent in WIN-exposed males (<xref ref-type="fig" rid="fig4">Figure 4A–B</xref>). Strikingly, LTD was normal in PCE female littermates (<xref ref-type="fig" rid="fig4">Figure 4C–D</xref>). In a second series of experiments a similar sex-specific ablation of eCB-LTD in the progeny of dams exposed to THC, the main psychoactive component of cannabis, was observed (5 mg/kg, s.c. GD5-20; <xref ref-type="fig" rid="fig5">Figure 5</xref>).</p><fig-group><fig id="fig4" position="float"><object-id pub-id-type="doi">10.7554/eLife.36234.007</object-id><label>Figure 4.</label><caption><title>Sexual divergent ablation of LTD in the PFC of adult rats prenatally exposed to WIN.</title><p>(<bold>A</bold>) Average time-courses of mea field EPSPs showing that low-frequency stimulation (10 min at 10 Hz, arrow) induced LTD of evoked fEPSPs recorded in the mPFC in SHAM (n = 7; white circles), but not in WIN (n = 17; green circles) prenatally-exposed male rats. Above: example traces, baseline (1) and 40 min post-stimulation (2). (<bold>B</bold>) Individual experiments (grey) and group average (white represents SHAM; green represents WIN), before (baseline) and after (40 min) LTD induction showing the lack of LTD in the WIN exposed group. In SHAM rats: 0.185 ± 0.006 mV before LTD versus 0.150 ± 0.007 mV after LTD induction (n = 7, p&lt;0.05, paired t-test). In WIN animals: 0.197 ± 0.008 mV before LTD versus 0.189 ± 0.009 mV after LTD induction (n = 17, p&gt;0.05, paired t-test). (<bold>C</bold>) Average time-courses of mean EPSPs showing similar low-frequency LTD in SHAM (n = 5; white circles) and WIN (n = 13; orange circles) in utero-exposed female rats. Above: example traces, baseline (1) and 40 min post-stimulation (2). (<bold>D</bold>) Individual experiments (grey) and group average (white represents SHAM; orange represents WIN), before (baseline) and after (40 min) LTD induction showing that prenatal WIN exposure does not alter LTD in the female exposed group. In SHAM female rats: 0.204 ± 0.009 mV before LTD versus 0.168 ± 0.010 mV after LTD induction (n = 5, p&lt;0.05, paired t-test). In WIN female rats: 0.255 ± 0.012 mV before LTD versus 0.214 ± 0.013 mV after LTD induction (n = 13, p&lt;0.05, paired t-test). *p&lt;0.05. n = individual rats. Error bars indicate SEM. Scale bar: 10 ms, 0.1 mV.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-36234-fig4-v2"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.36234.008</object-id><label>Figure 4—figure supplement 1.</label><caption><title>mGlu<sub>2/3</sub>-LTD and long-term potentiation are spared by prenatal WIN exposure.</title><p>(<bold>A, B</bold>) Prenatal exposure to cannabinoids does not alter mGlu<sub>2/3</sub>-LTD. Average time of mean fEPSPs showing that mGlu<sub>2/3</sub>-agonist induced LTD (bath application of LY379268, 30 nM, 10 min) is identical in SHAM and WIN exposed male (<bold>A</bold>): SHAM, n = 6, white circles; WIN, n = 6, green circles) and female (<bold>B</bold>): SHAM, n = 4, white circles; WIN, n = 6, orange circles). (<bold>C</bold>) Average time-courses of mean fEPSPs showing that theta burst stimulation (indicated by arrow) induces LTP at layer V/VI mPFC synapses in both SHAM- (white circles, n = 8) and WIN- (green circles, n = 8) exposed male rats. (<bold>D</bold>) Individual averaged fEPSP amplitude measurements before (baseline) and 40 min after LTP induction. Grey, individual experiments; tan, group averages. In SHAM rats: 0.138 ± 0.011 mV before LTP versus 0.185 ± 0.016 mV after LTP induction (n = 8, p&lt;0.05, paired t-test). In WIN male rats: 0.129 ± 0.012 mV before LTP versus 0.177 ± 0.015 mV after LTP induction (n = 13, p&lt;0.05, paired t-test). (<bold>E</bold>) Identical TBS-LTP induction protocol but recording from female prenatally-exposed animals (SHAM, white circles, n = 8; WIN, orange circles, n = 8). (<bold>F</bold>) Peak amplitude measurements before (baseline) and after (LTP) stimulation protocol from individual experiments (grey) and group averages in SHAM (white; 0.125 ± 0.014 mV before LTP versus 0.150 ± 0.020 mV after LTP; p&lt;0.05, paired t-test) and WIN (orange; 0.133 ± 0.010 mV before LTP versus 0.167 ± 0.016 mV after LTP; p&lt;0.05, paired t-test) animals. *p&lt;0.05. n = individual rats. Error bars represent SEM.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-36234-fig4-figsupp1-v2"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.36234.009</object-id><label>Figure 4—figure supplement 2.</label><caption><title>Prenatal THC does not alter long-term potentiation.</title><p>(<bold>A</bold>) Average time-courses of mean fEPSPs showing that theta burst stimulation (indicated by arrow) induces LTP at layer V/VI mPFC synapses in both SHAM- (white circles, n = 8) and THC- (green circles, n = 8) exposed male rats. (<bold>B</bold>) Individual averaged fEPSP amplitude measurements before (baseline) and 40 min after LTP induction. Grey, individual experiments; tan, group averages. In SHAM rats: 0.138 ± 0.011 mV before LTP versus 0.185 ± 0.016 mV after LTP induction (n = 8, p&lt;0.05, paired t-test). In THC male rats: 0.129 ± 0.012 mV before LTP versus 0.177 ± 0.015 mV after LTP induction (n = 13, p&lt;0.05, paired t-test). (<bold>C</bold>) Identical TBS-LTP induction protocol but recording from female prenatally-exposed animals (SHAM, white circles, n = 8; THC, orange circles, n = 8). (<bold>D</bold>) Peak amplitude measurements before (baseline) and after (LTP) stimulation protocol from individual experiments (grey) and group averages in SHAM (white, 0.125 ± 0.014 mV before LTP versus 0.150 ± 0.020 mV after LTP; p&lt;0.05, paired t-test) and THC (orange; 0.133 ± 0.010 mV before LTP versus 0.167 ± 0.016 mV after. LTP; p&lt;0.05, paired t-test) animals. *p&lt;0.05. n = individual rats. Error bars represent SEM.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-36234-fig4-figsupp2-v2"/></fig><fig id="fig4s3" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.36234.010</object-id><label>Figure 4—figure supplement 3.</label><caption><title>Prenatal cannabinoid exposure does not modify synaptic CB1R potency or efficiency.</title><p>Dose-response curve for the cannabimimetic CP55,940 in SHAM (white symbols, n = 6–9 animals, EC<sub>50</sub> = 0.240 μM, top value 42.01%, 95% CI for EC<sub>50</sub> = 0.088–0.658) and WIN-exposed (green symbols, n = 5–6, EC<sub>50</sub> = 0.085 μM, top value 35.09%, 95% CI for EC<sub>50</sub> = 0.025–0.292) male rats. fEPSP amplitudes were measured 30 min after application of CP55,940. Each point is expressed as the percentage of inhibition of its basal value. Error bars indicate SEM.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-36234-fig4-figsupp3-v2"/></fig></fig-group><fig id="fig5" position="float"><object-id pub-id-type="doi">10.7554/eLife.36234.011</object-id><label>Figure 5.</label><caption><title>Sexual divergent ablation of LTD in the PFC of adult rats prenatally exposed to THC.</title><p>(<bold>A</bold>) Average time-courses of men field EPSPs showing that low-frequency stimulation (10 min at 10 Hz, arrow) induced LTD of evoked fEPSPs recorded in the mPFC in SHAM (n = 4; white circles), but not in THC (n = 6; green circles) prenatally-exposed male rats. Above: example traces, baseline (1) and 40-min poststimulation (2). (<bold>B</bold>) Individual experiments (grey) and group average (white represents SHAM; green represents THC), before (baseline) and after (40 min) LTD induction showing the lack of LTD in the THC exposed group. In SHAM rats: 0.239 ± 0.030 mV before LTD versus 0.202 ± 0.028 mV after LTD induction (n = 4, p&lt;0.05, paired t-test). In THC animals: 0.244 ± 0.023 mV before LTD versus 0.236 ± 0.019 mV after LTD induction (n = 6, p&gt;0.05, paired t-test). (<bold>C</bold>) Average time-courses of mean EPSPs showing similar low-frequency LTD in SHAM (n = 6; white circles) and THC (n = 4; orange circles) in utero-exposed female rats. Above: example traces, baseline (1) and 40 min poststimulation (2). (<bold>D</bold>) Individual experiments (grey) and group average (white represents SHAM; orange represents THC), before (baseline) and after (40 min) LTD induction showing that prenatal THC exposure does not alter LTD in the female exposed group. In SHAM female rats: 0.211 ± 0.011 mV before LTD versus 0.183 ± 0.010 mV after LTD induction (n = 6, p&lt;0.05, paired t-test). In THC female rats: 0.234 ± 0.030 mV before LTD versus 0.177 ± 0.030 mV after LTD induction (n = 4, p&lt;0.05, paired t-test). *p&lt;0.05. n = individual rats. Error bars indicate SEM. Scale bar: 10 ms, 0.1 mV.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-36234-fig5-v2"/></fig><p>To test if the effects of PCE extend to other forms of plasticity expressed at excitatory mPFC synapses we assessed two critical actors of bidirectional plasticity and reliable prefrontal endophenotypes of neuropsychiatric diseases: mGlu<sub>2/3</sub>-dependent LTD and NMDAR-dependent LTP (<xref ref-type="bibr" rid="bib32">Iafrati et al., 2014</xref>; <xref ref-type="bibr" rid="bib33">Iafrati et al., 2016</xref>; <xref ref-type="bibr" rid="bib37">Kasanetz et al., 2013</xref>; <xref ref-type="bibr" rid="bib75">Thomazeau et al., 2014</xref>). In contrast to the lack of eCB-LTD, mGlu<sub>2/3</sub>-mediated LTD was indistinguishable in SHAM- and WIN-exposed male and female (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1 A-B</xref> ). Similarly, theta-burst stimulation (TBS) induces similar levels of NMDAR-dependent LTP at mPFC pyramidal synapses independent of sex and prenatal treatment (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1 C-D-E-F</xref>). We also confirmed that prenatal THC does not affect prefrontal LTP at adulthood (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>).</p><p>Together the data reveal eCB-LTD in the mPFC as sex-specific target of in-utero cannabinoid exposure.</p></sec><sec id="s2-3"><title>Cannabinoid prenatal exposure causes sex-specific modifications in pyramidal neuron properties</title><p>Activity-induced modulation of intrinsic excitability is a powerful mean to control cortical circuits (<xref ref-type="bibr" rid="bib3">Bacci et al., 2005</xref>; <xref ref-type="bibr" rid="bib16">Debanne and Poo, 2010</xref>) postulated to contribute to disorders of the CNS. To test the hypothesis that PCE altered prefrontal excitability, intrinsic firing properties of pyramidal neurons in our animal groups were compared. Sexual differences to the effects of prenatal exposure to cannabinoids were visible at this cellular level. Specifically, mPFC neurons in WIN-exposed rats showed impaired membrane reaction profiles in response to a series of somatic current steps (<xref ref-type="fig" rid="fig6">Figure 6A and E</xref>). Independent of the sex and treatment, the resting potential was similar (<xref ref-type="fig" rid="fig6">Figure 6B and F</xref>). While the rheobase (<xref ref-type="fig" rid="fig6">Figure 6C and G</xref>) was decreased in males prenatally exposed to WIN, females were spared. Moreover, this hyper-excitability in exposed-males was accompanied by an increased number of action potentials in response to somatic currents steps (<xref ref-type="fig" rid="fig6">Figure 6D</xref>). Similar results have been obtained in the rat progeny of dams treated with THC during gestation (<xref ref-type="fig" rid="fig7">Figure 7</xref>). Thus, PCE leads to an increased excitability of deep layers mPFC pyramidal cells in male progeny only.</p><fig id="fig6" position="float"><object-id pub-id-type="doi">10.7554/eLife.36234.012</object-id><label>Figure 6.</label><caption><title>Prenatal WIN exposure induces sex-specific alteration of intrinsic properties of layer five prefrontal pyramidal neurons in adult rats.</title><p>(<bold>A</bold>) Left, Current-voltage (I–V) curves recorded in SHAM (n = 19 cells/10 rats, white circles) and WIN-exposed rats (n = 23 cells/12 rats, green circles) showing altered membrane potentials in male from the in utero cannabinoid group (F<sub>(10, 400)</sub>=10.07, p&lt;0.05, two-way ANOVA). Right, typical membrane response to somatic current steps from SHAM (up) and WIN- (down) exposed male. (<bold>B</bold>) The resting membrane potential was similar in both SHAM and WIN male groups (p&gt;0.05, Mann-Whitney U test). (<bold>C</bold>) The rheobase was reduced in WIN-exposed male rats compared to the SHAM male (p&lt;0.05, Mann-Whitney U test). (<bold>D</bold>) The number of evoked action potentials in response to increasing depolarizing current steps was higher in WIN in-utero treated male compared to SHAM animals (F<sub>(18, 720)</sub>=6.652, p&lt;0.05, two-way ANOVA). (<bold>E</bold>) Left, In contrast, I-V curves were similar in SHAM (n = 15 cells/9 rats, white circles) and WIN-exposed female (n = 22 cells/12 rats, orange circles; F<sub>(9, 315)</sub>=1.091, p&gt;0.05, two-way ANOVA). Right, typical membrane response to somatic current steps from SHAM (up) and WIN- (down) exposed females. (<bold>F,G</bold>) The resting membrane potential and the rheobase were not impacted in females (<bold>F,G</bold>) p&gt;0.05, Mann-Whitney U test). (<bold>H</bold>) The number of action potentials was not altered in females after an in utero treatment (F<sub>(12, 455)</sub>=0.079, p&gt;0.05, two-way ANOVA). *p&lt;0.05. Error bars represent SEM.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-36234-fig6-v2"/></fig><fig id="fig7" position="float"><object-id pub-id-type="doi">10.7554/eLife.36234.013</object-id><label>Figure 7.</label><caption><title>Prenatal THC exposure induces sex-specific alteration of intrinsic properties of layer five prefrontal pyramidal neurons in adult rats.</title><p>(<bold>A</bold>) Current-voltage (I–V) curves recorded in SHAM (n = 8 cells/5 rats, white circles) and THC-exposed rats (n = 10 cells/5 rats, green circles) showing altered membrane potentials in male after an in utero cannabinoid exposure (F<sub>(26, 416)</sub>=1.987, p&lt;0.05, two-way ANOVA). (<bold>B</bold>): In contrast, I-V curves were similar in SHAM group (n = 15 cells/7 rats, white circles) and THC-exposed group (n = 24 cells/7 rats, orange circles; F<sub>(26, 962)</sub>=0.534, p&gt;0.05, two-way ANOVA). (<bold>C,D</bold>): The resting membrane potential was similar in both male (<bold>C</bold>) and female (<bold>D</bold>) rats after an in utero exposure to THC (p&gt;0.05, Mann-Whitney U test). (<bold>E,F</bold>): The rheobase was reduced in THC-exposed male rats compared to the SHAM male (<bold>E</bold>); p&lt;0.05, Mann-Whitney U test) whereas it was not altered in female (<bold>F</bold>); p&gt;0.05, Mann-Whitney U test). (<bold>G</bold>): The number of evoked action potentials in response to several depolarizing current steps was higher in THC in utero treated male compared to SHAM animals (F<sub>(18, 288)</sub>=3.764, p&lt;0.05, two-way ANOVA). (<bold>H</bold>): The number of action potential was also altered in female after an in utero treatment with THC (F<sub>(18, 666)</sub>=1.320, p&lt;0.05, two-way ANOVA). Error bars represent SEM.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-36234-fig7-v2"/></fig></sec><sec id="s2-4"><title>Sex-differences in mRNA expression levels</title><p>Motivated by the eCB-LTD deficiency in layer 5 mPFC of the male PCE progeny, we surveyed mRNA levels of key components of the endocannabinoid system in adult PCE rats using real time quantitative PCR (<xref ref-type="fig" rid="fig8">Figure 8</xref> and <xref ref-type="table" rid="table2">Table 2</xref>). Key differences were decreased levels of mRNA for TRPV1, mGlu5, and DAGLα in the female PCE offspring and decreased levels of mGlu5 mRNA in the male offspring (<xref ref-type="fig" rid="fig8">Figure 8</xref>). A mild increase was seen in mGlu1 in the PCE males (<xref ref-type="table" rid="table2">Table 2</xref>). No differences were seen in other endocannabinoid system mRNAs after PCE, including CB1, CB2, DAGLβ, NAPE-PLD, FAAH, ABHD6, or CRIP1a (<xref ref-type="table" rid="table2">Table 2</xref>).</p><fig id="fig8" position="float"><object-id pub-id-type="doi">10.7554/eLife.36234.014</object-id><label>Figure 8.</label><caption><title>Prenatal cannabinoid treatment affects expression of endocannabinoid system components in a sex-dependent fashion.</title><p>CB1, TRPV1, mGlu5, and DAGLα mRNA levels in medial prefrontal cortex at PND90 were determined by real-time PCR in male (<bold>A, C, E, and G</bold>) and female (<bold>B, D, F, and H</bold>) rats using Taqman probes and a QuantStudio7 thermocycler. Treatment of dams with WIN from GD5 to GD20 decreased TRPV1, mGlu5, and DAGLα mRNA in female offspring. However, the same treatment decreased only mGlu5 in male offspring. *p&lt;0.05. Error bars represent SEM.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-36234-fig8-v2"/></fig><table-wrap id="table2" position="float"><object-id pub-id-type="doi">10.7554/eLife.36234.015</object-id><label>Table 2.</label><caption><title>Statistical significance of gene expression changes in adult rat medial prefrontal cortex after in utero WIN treatment.</title><p>The levels of mRNA’s of interest were determined from medical prefrontal cortex punches using qPCR (See Materials and methods for details). Statistical significance was determined using the unpaired Student’s t-test after outliers were detected and removed from the dataset using Grubbs’ test. p-Values of less than 0.05 are identified by bold text in the table. Relative expression levels for CB1, TRPV1, mGluR5 and DAGL-alpha are shown in <xref ref-type="fig" rid="fig10">Figure 10</xref>.</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th colspan="3">MALE</th><th colspan="3">Female</th></tr><tr><th>Targets</th><th>Treatment</th><th>N</th><th>p-Value <break/>(Unpaired t-test)</th><th>Treatment</th><th>N</th><th>p-Value <break/>(Unpaired <break/>t-test)</th></tr></thead><tbody><tr><td rowspan="2">CB1</td><td>SHAM</td><td>8</td><td rowspan="2">0.3279</td><td>SHAM</td><td>7</td><td rowspan="2">0.0643</td></tr><tr><td>WIN</td><td>8</td><td>WIN</td><td>8</td></tr><tr><td rowspan="2">CB2</td><td>SHAM</td><td>7</td><td rowspan="2">0.9379</td><td>SHAM</td><td>6</td><td rowspan="2">0.1427</td></tr><tr><td>WIN</td><td>7</td><td>WIN</td><td>7</td></tr><tr><td rowspan="2">TRPV1</td><td>SHAM</td><td>7</td><td rowspan="2">0.2281</td><td>SHAM</td><td>8</td><td rowspan="2"><bold>0.0098</bold></td></tr><tr><td>WIN</td><td>8</td><td>WIN</td><td>7</td></tr><tr><td rowspan="2">mGlu5</td><td>SHAM</td><td>7</td><td rowspan="2"><bold>0.0273</bold></td><td>SHAM</td><td>8</td><td rowspan="2"><bold>0.0092</bold></td></tr><tr><td>WIN</td><td>7</td><td>WIN</td><td>7</td></tr><tr><td rowspan="2">mGlu1</td><td>SHAM</td><td>8</td><td rowspan="2"><bold>0.0400</bold></td><td>SHAM</td><td>7</td><td rowspan="2">0.3910</td></tr><tr><td>WIN</td><td>8</td><td>WIN</td><td>8</td></tr><tr><td rowspan="2">DAGL alpha</td><td>SHAM</td><td>8</td><td rowspan="2">0.4370</td><td>SHAM</td><td>8</td><td rowspan="2"><bold>0.0024</bold></td></tr><tr><td>WIN</td><td>8</td><td>WIN</td><td>8</td></tr><tr><td rowspan="2">DAGL beta</td><td>SHAM</td><td>7</td><td rowspan="2">0.4218</td><td>SHAM</td><td>6</td><td rowspan="2">0.3783</td></tr><tr><td>WIN</td><td>7</td><td>WIN</td><td>7</td></tr><tr><td rowspan="2">NAPE-PLD</td><td>SHAM</td><td>7</td><td rowspan="2">0.4258</td><td>SHAM</td><td>7</td><td rowspan="2">0.7518</td></tr><tr><td>WIN</td><td>7</td><td>WIN</td><td>7</td></tr><tr><td rowspan="2">MAGL</td><td>SHAM</td><td>8</td><td rowspan="2">0.5097</td><td>SHAM</td><td>8</td><td rowspan="2">0.2147</td></tr><tr><td>WIN</td><td>8</td><td>WIN</td><td>8</td></tr><tr><td rowspan="2">FAAH</td><td>SHAM</td><td>8</td><td rowspan="2">0.5505</td><td>SHAM</td><td>8</td><td rowspan="2">0.4096</td></tr><tr><td>WIN</td><td>8</td><td>WIN</td><td>7</td></tr><tr><td rowspan="2">ABHD6</td><td>SHAM</td><td>7</td><td rowspan="2">0.2437</td><td>SHAM</td><td>6</td><td rowspan="2">0.6014</td></tr><tr><td>WIN</td><td>7</td><td>WIN</td><td>7</td></tr><tr><td rowspan="2">CRIP1a</td><td>SHAM</td><td>7</td><td rowspan="2">0.6414</td><td>SHAM</td><td>7</td><td rowspan="2">0.1887</td></tr><tr><td>WIN</td><td>7</td><td>WIN</td><td>7</td></tr></tbody></table></table-wrap></sec><sec id="s2-5"><title>Positive allosteric modulation of mGlu<sub>5</sub> corrects synaptic and behavioral deficits associated with prenatal cannabinoid male exposure</title><p>The present data reveal a down-regulation of mGlu<sub>5</sub> RNA expression levels in the mPFC of PCE males. Previous work from our group underlies the efficiency of mGlu<sub>5</sub> positive allosteric modulation in correcting synaptic and behavioral deficits (<xref ref-type="bibr" rid="bib50">Manduca et al., 2017</xref>; <xref ref-type="bibr" rid="bib57">Martin et al., 2017</xref>).</p><p>Thus, we tested whether amplification of mGlu<sub>5</sub>, an effector of eCB-signaling complex in the PFC, could normalize LTD in PCE male. To this aim, we used CDPPB (10 μM), a well-described positive allosteric modulator (PAM) of mGlu<sub>5</sub>. We found that CDPPB fully restored the ability of excitatory mPFC synapses to express LTD in the prenatally WIN-exposed male group (<xref ref-type="fig" rid="fig9">Figure 9A–B</xref>). To verify that the curative properties of CDPPB were indeed due to eCB production, we tested the effects of CB1R and TRPV1 antagonists on the CDPPB rescue. Interestingly, preincubation with either SR141716A or capsazepine prevented the CDPPB rescue of synaptic plasticity (<xref ref-type="fig" rid="fig9">Figure 9C–D</xref>). Thus, the data showed that both receptors are engaged in the presence of the mGlu<sub>5</sub> PAM.</p><fig id="fig9" position="float"><object-id pub-id-type="doi">10.7554/eLife.36234.016</object-id><label>Figure 9.</label><caption><title>Positive allosteric modulation of mGlu<sub>5</sub> restores LTD and normalizes social interaction in male rats prenatally exposed to WIN.</title><p>(<bold>A</bold>) Average time-courses of mean field EPSPs showing that, in WIN-exposed males (WIN, n = 17, green circle), LTD can be restored with the mGlu<sub>5</sub>positive allosteric modulator CDPPB (10 μM, n = 4, blue navy circle). (<bold>B</bold>) Peak amplitude measurements before (baseline) and after (LTD) stimulation protocol from individual experiments in absence or presence of CDPPB. After 45 min CDPPB preincubation: 0.190 ± 0.004 mV before and 0.147 ± 0.012 after LTD induction (n = 4, p&lt;0.05, paired t-test). (<bold>C</bold>) Time course of fEPSP during 10 Hz stimulus evoked LTD (arrow, 10 min) in presence of CB1R antagonist SR141716 (SR, 4 μM, n = 5, blue circles) or TRPV1 antagonist Capsazepine (CPZ, 10 μM, n = 3, black circles) in WIN-exposed males. (<bold>D</bold>) Individual averaged fEPSP amplitude experiments before (baseline) and 40 min after 10 Hz LTD stimulation (LTD). CB1R were necessary for the CDPPB effect on LTD: SR141716A preincubation blocked LTD induction in the presence of CDPPB: 0.206 ± 0.019 mV before and 0.217 ± 0.026 (blue circle, n = 5, p&gt;0.05, paired t-test). Similarly, the TRPV1 antagonist inhibits the restorative effects of CDPPB: 0.220 ± 0.009 mV before LTD and 0.212 ± 0.012 mV after LTD induction (black circle, n = 3, p&lt;0.05, paired t-test). (<bold>E–F</bold>) Systemic administration of CDPPB (0.75 mg/Kg, i.p.) normalized the altered social behavior in male rats prenatally exposed to WIN (number of contacts: E: F(<sub>WIN in utero x CDPPB</sub>)<sub>1,20</sub>=1.867, p=0.187, two-way ANOVA; time interaction: F: F(<sub>WIN in utero x CDPPB</sub>)<sub>1,20</sub>=1.607, p=0.219, two-way ANOVA). (<bold>G-H</bold>) Pre-treatment with SR141716A (1 mg/kg, i.p.) prevents the ameliorative actions of CDPPB (0.75 mg/Kg, i.p.) on social interaction. Similarly, the TRPV1 antagonist blocks the restorative effects of CDPPB on social interaction in adult rats prenatally exposed to WIN (number of contacts: G: F<sub>3,30</sub>=22.36, p&lt;0.05, one-way ANOVA; time interaction: H: F<sub>3,30</sub>=25.95, p&lt;0.05, one-way ANOVA). Scatter dot plot represents a pair of animals. Error bars indicate SEM. *p&lt;0.05. Student–Newman–Keuls test.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-36234-fig9-v2"/></fig><p>Strikingly, we found that systemic CDPPB normalized social cognition in the PCE group but remained without effect in the SHAM group, indicating selectivity of the drug's effects to the disease-state (<xref ref-type="fig" rid="fig9">Figure 9E–F</xref>). In agreement with the synaptic plasticity experiments, pre-treatment with either SR141716A (<xref ref-type="fig" rid="fig9">Figure 9G–H</xref>) or capsazepine prevented the ameliorative actions of CDPPB (<xref ref-type="fig" rid="fig9">Figure 9G–H</xref>). Thus, potentiating mGlu<sub>5</sub> signaling normalized synaptic and behavioral deficits induced by prenatal exposure to cannabinoids via CB1R and TRPV1 activation.</p></sec><sec id="s2-6"><title>TRPV1, not CB1R, mediate LTD in PCE female</title><p>The observation that PCE did not alter CB1R RNA levels in either sex but lowered TRPV1R in the female PCE progeny (<xref ref-type="fig" rid="fig8">Figure 8</xref>, <xref ref-type="table" rid="table2">Table 2</xref>) drew our attention to the role of these two receptors at PFC synapses. Comparing full dose-response curves for the CB1 agonist CP55,940 in male SHAM vs PCE revealed no differences (<xref ref-type="fig" rid="fig4s3">Figure 4—figure supplement 3</xref>). Thus, the lack of LTD in PCE males cannot readily be attributed to altered sensitivity of presynaptic CB1R. We and others have shown that central excitatory synapses can engage TRPV1R and/or CB1R to trigger LTD (<xref ref-type="bibr" rid="bib13">Chávez et al., 2010</xref>; <xref ref-type="bibr" rid="bib26">Grueter et al., 2010</xref>; <xref ref-type="bibr" rid="bib57">Martin et al., 2017</xref>; <xref ref-type="bibr" rid="bib66">Puente et al., 2011</xref>). In PCE females, LTD was fully expressed in the presence of a specific CB1R antagonist (SR141716A 5 μM, <xref ref-type="fig" rid="fig10">Figure 10A–B–C</xref>) but completely prevented by TRPV1R antagonists (capsazepine 10 µM, <xref ref-type="fig" rid="fig10">Figure 10A–B–C</xref>). Thus, TRPV1R rather than CB1R mediates LTD in female PCE. This contribution of TRPV1R to LTD in female PCE could be part of the adaptive response to PCE or a previously unnoticed sexual difference in the mechanism of prefrontal synaptic plasticity. We next investigated the substrate of LTD in naive male and female rats (<xref ref-type="fig" rid="fig11">Figure 11</xref>). As expected from over a decade of studies in male rodents (<xref ref-type="bibr" rid="bib5">Bender et al., 2006</xref>; <xref ref-type="bibr" rid="bib14">Chevaleyre et al., 2006</xref>; <xref ref-type="bibr" rid="bib22">Gerdeman et al., 2002</xref>; <xref ref-type="bibr" rid="bib34">Iremonger et al., 2011</xref>; <xref ref-type="bibr" rid="bib44">Lafourcade et al., 2007</xref>; <xref ref-type="bibr" rid="bib52">Marsicano et al., 2002</xref>; <xref ref-type="bibr" rid="bib64">Nevian and Sakmann, 2006</xref>; <xref ref-type="bibr" rid="bib66">Puente et al., 2011</xref>; <xref ref-type="bibr" rid="bib69">Robbe et al., 2002a</xref>) the CB1R antagonist prevented LTD induction in rat male slices (<xref ref-type="fig" rid="fig11">Figure 11D,E,F</xref> and <xref ref-type="fig" rid="fig11s1">Figure 11— figure supplement 1)</xref>). Unexpectedly (<xref ref-type="bibr" rid="bib72">Rubino et al., 2015</xref>), the same treatment was without effect in female slices (<xref ref-type="fig" rid="fig11">Figure 11A–B–C</xref>). In contrast, antagonism of TRPV1R was without effect in males (<xref ref-type="fig" rid="fig11">Figure 11A–C</xref>) but prevented the induction of eCB-LTD in females (<xref ref-type="fig" rid="fig11">Figure 11D–E–F</xref>).</p><fig id="fig10" position="float"><object-id pub-id-type="doi">10.7554/eLife.36234.017</object-id><label>Figure 10.</label><caption><title>In prenatally exposed female, TRPV1 receptors mediate LTD, not CB1R.</title><p>(<bold>A</bold>) Average time course of mean fEPSPs showing that LTD (arrow) is inhibited by the selective TRPV1 antagonist capsazepine (CPZ, black circles, n = 5) but not the CB1R antagonist SR141617A (SR, blue circles, n = 5) in WIN in utero exposed female rats. (<bold>B</bold>) Summary bar chart of percent LTD calculated from normalized fEPSPs measured 40 min after 10 Hz protocol showing that LTD is blocked by TRPV1 antagonist (black bar) but not by CB1R antagonist (blue bar; p&gt;0.05, one-way ANOVA). Above: example traces, baseline (1) and 40 min poststimulation (2). (<bold>C</bold>) Plot of individual experiments (grey) showing fEPSP areas before (baseline) and 40 min after stimulation protocol (LTD) in absence (orange, n = 13; p&lt;0.05, paired t-test) and presence of SR141716A (SR, blue, n = 5; p&lt;0.05, paired t-test) or Capsazepine (CPZ, black, n = 5; p&gt;0.05, paired t-test) from WIN-exposed female rats. *p&lt;0.05. n = individual rats. Error bars represent SEM. Scale bar: 10 ms, 0.1 mV.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-36234-fig10-v2"/></fig><fig-group><fig id="fig11" position="float"><object-id pub-id-type="doi">10.7554/eLife.36234.018</object-id><label>Figure 11.</label><caption><title>Sex-specific substrates of LTD in adult mPFC.</title><p>(<bold>A</bold>) Time course of normalized field EPSPs recordings from layer 5 mPFC after 10 Hz stimulation protocol (10 min, arrow) in presence of CB1R antagonist SR141716 (SR, n = 6, blue circles) or TRPV1 antagonist Capsazepine (CPZ, n = 3, black circles) in naïve female rats. Right: example traces, baseline (1) and 40 min poststimulation (2)(<bold>B</bold>) Individual experiments (grey) and group average (tan circles), before (baseline) and after (40 min) LTD induction (arrow) showing that, in control female rat (CTRL, left), LTD is blocked by the TRPV1 antagonist (CPZ, right) but not by the CB1R antagonist (SR, middle). In control rats: 1.368 ± 0.089 mV.ms before LTD versus 1.205 ± 0.074 after LTD induction (n = 6; p&lt;0.05, paired t-test). After SR141716A preincubation: 1.970 ± 0.160 mV.ms before LTD versus 1.420 ± 0.133 after LTD induction (n = 6; p&lt;0.05, paired t-test). In control female, LTD induction requires activation of TRPV1 receptors: 1.463 ± 0.295 mV.ms before LTD versus 1.497 ± 0.300 after LTD induction (n = 3; p&gt;0.05, paired t-test). (<bold>C</bold>) Bar chart summary of fEPSP percentage change from baseline 38–40 min after 10 Hz stimulation in control female (white bar) after treatment with CB1R antagonist (SR, blue bar) or TRPV1 antagonist (CPZ, black bar) (F<sub>(2, 12)</sub>=3.928; p&lt;0.05, one-way ANOVA). (<bold>D</bold>) Time course of normalized field EPSPS recordings from layer 5 mPFC after 10 Hz stimulation protocol (10 min, arrow) in presence of CB1R antagonist SR141716 (SR, n = 4, blue circles) or TRPV1 antagonist Capsazepine (CPZ, n = 4, black circles) in naive male rats. Right: example traces, baseline (1) and 40 min poststimulation (2). (<bold>E</bold>) Individual experiments (grey) and group average (colors), before (bsl) and after (40 min) LTD induction showing that LTD in control male rats is CB1R-mediated (middle) rather than TRPV1-mediated (right). Low-frequency stimulation of mPFC slices triggers LTD in male (left, white): 1.704 ± 0.107 mV.ms before 10 Hz stimulation versus 1.367 ± 0.112 after LTD induction (n = 9; p&lt;0.05, paired t-test). This LTD is blocked by CB1R antagonist SR141716A: 1.565 ± 0.185 mV.ms before and 1.480 ± 0.167 after LTD induction (n = 4; p&gt;0.05, paired t-test). In contrast, in male rats, LTD is not blocked by TRPV1 antagonist: 1.917 ± 0.256 mV.ms before LTD versus 1.644 ± 0.204 after LTD induction (n = 4; p&lt;0.05, paired t-test). (<bold>F</bold>) Bar chart summary of fEPSP percentage change from baseline 38–40 min after LTD induction in control male (white bar) after treatment with CB1R antagonist (SR, blue bar) or TRPV1 antagonist (CPZ, black bar) (F<sub>(2, 14)</sub>=7.623; p&lt;0.05, one-way ANOVA). mPFC slices were preincubated for 45 min in 5 μM SR141716A and 10 μM Capsazepine. *p&lt;0.05. n = individual rats. Error bars indicate SEM. Scale bar: 10 ms, 0.1 mV.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-36234-fig11-v2"/></fig><fig id="fig11s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.36234.019</object-id><label>Figure 11—figure supplement 1.</label><caption><title>Sex-specific substrates of LTD in naïve adult mPFC.</title><p>(<bold>A</bold>) Time course of normalized field EPSPs recordings from layer 5 mPFC after 10 Hz stimulation protocol (10 min, arrow) in presence of the selective CB1R antagonist NESS0327 (n = 7, blue circles) or TRPV1 antagonist AMG9810 (n = 7, grey circles) in naïve male rats. (<bold>B</bold>) Individual experiments (grey) and group average (tan circles), before (baseline) and after (40 min) LTD induction (arrow) showing that, in control male rats (CTRL, left), LTD is blocked by the CB1R antagonist (NESS0327, middle) but not by the TRPV1 antagonist (AMG9810, right). In control rats: 0.239 ± 0.019 mV before LTD versus 0.175 ± 0.015 after LTD induction (n = 7; p&lt;0.05, paired t-test). After NESS0327 preincubation: 0.223 ± 0.015 mV before LTD versus 0.208 ± 0.024 after LTD induction (n = 7; p&gt;0.05, paired t-test). In naive males, LTD induction did not require activation of TRPV1 receptors: 0.258 ± 0.024 mV before LTD versus 0.204 ± 0.024 after LTD induction (n = 7; p&lt;0.05, paired t-test). (<bold>C</bold>) Time course of normalized field EPSPs recordings from layer 5 mPFC after 10 Hz stimulation protocol (10 min, arrow) in presence of CB1R antagonist NESS0327 (n = 8, blue circles) or TRPV1 antagonist AMG9810 (n = 6, grey circles) in naive female rats. (<bold>D</bold>) Individual experiments (grey) and group average (colors), before (baseline) and after (40 min) LTD induction showing that LTD in control female rats is TRPV1R-mediated (right) rather than CB1R-mediated (middle). Low-frequency stimulation of mPFC slices triggers LTD in female (left, white): 0.254 ± 0.034 mV before 10 Hz stimulation versus 0.191 ± 0.031 after LTD induction (n = 5; p&lt;0.05, paired t-test). This LTD is blocked by TRPV1R antagonist AMG9810: 0.216 ± 0.016 mV before and 0.204 ± 0.012 after LTD induction (n = 6; p&gt;0.05, paired t-test). In contrast, in female rats, LTD is not blocked by CB1R antagonist: 0.204 ± 0.013 mV before LTD versus 0.162 ± 0.011 after LTD induction (n = 8; p&lt;0.05, paired t-test). mPFC slices were preincubated for 45 min in 1 μM NESS0327 and 3 μM AMG9810. *p&lt;0.05. n = individual rats. Error bars indicate SEM. Scale bar: 10 ms, 0.1 mV.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-36234-fig11-figsupp1-v2"/></fig></fig-group><p>We confirmed and extended these findings with two other antagonists: the CB1R selective neutral antagonist NESS0327 (1 μM, Cayman Chemical, <xref ref-type="fig" rid="fig11s1">Figure 11—figure supplement 1A-B</xref>) but not the selective TRPV1R antagonist AMG9810 (3 µM, Tocris, <xref ref-type="fig" rid="fig11s1">Figure 11—figure supplement 1A-B</xref>) prevented LTD induction in naive male rat slices. Conversely, AMG9810 but not NESS0327 prevented the induction of LTD in naive female adult animals (<xref ref-type="fig" rid="fig11s1">Figure 11—figure supplement 1 C-D</xref> ).</p></sec><sec id="s2-7"><title>Enhancing anandamide levels corrects synaptic and behavioral deficits associated with prenatal cannabinoid male exposure</title><p>We thought of an additional strategy to reverse PCE-induced deficits based on our finding that TRPV1R mediates LTD in PCE females in spite of a down-regulation of TRPV1R RNA expression levels. Anandamide is an endogenous ligand of TRPV1 (<xref ref-type="bibr" rid="bib17">Di Marzo et al., 2002</xref>) and we hypothesized that inhibition of anandamide’s main degrading enzyme, fatty acid amid hydrolase (FAAH), would increase anandamide levels to the threshold for LTD induction in the PCE males (<xref ref-type="bibr" rid="bib72">Rubino et al., 2015</xref>). Indeed, incubation of mPFC slices prepared from PCE male rats with the FAAH inhibitor URB597 effectively restored eCB-LTD (<xref ref-type="fig" rid="fig12">Figure 12A–B</xref>). Interestingly, we found that pre-incubation with the specific TRPV1 antagonist capsazepine did not prevent the curative effect of URB597. Rather, the CB1R antagonist SR141716 blocked the URB597 rescue (<xref ref-type="fig" rid="fig12">Figure 12C–D</xref>). Previous studies have shown that endocannabinoids, including anandamide, mediate social behavior in rodents (<xref ref-type="bibr" rid="bib78">Trezza et al., 2012</xref>). We directly tested the hypothesis that elevating circulating levels of a main eCB, anandamide, could normalize social deficits. We found that in vivo treatment with the FAAH inhibitor (URB597, 0.1 mg/kg) normalized social deficits in adult male PCE rats (<xref ref-type="fig" rid="fig12">Figure 12E–F</xref>). In line with our mPFC slice results, SR141716A but not capsazepine prevented the curative actions of URB597 (<xref ref-type="fig" rid="fig12">Figure 12G–H</xref>). Thus, blocking anandamide degradation normalized social deficits via CB1R.</p><fig id="fig12" position="float"><object-id pub-id-type="doi">10.7554/eLife.36234.020</object-id><label>Figure 12.</label><caption><title>FAAH inhibition restores LTD and social interaction in male rats prenatally exposed to cannabinoids.</title><p>(<bold>A</bold>) Average tie-courses of mean fEPSPs after 10 Hz LTD protocol (1à min, arrow) in WIN-exposed mPFC slices preincubated for 45 min in 2 μM URB597, a FAAH inhibitor. (<bold>B</bold>) Individual experiments (grey) and group averages (tan circles), before (baseline) and after (40 min) LTD induction showing that, in WIN-exposed male (WIN, n = 17, green circle), LTD is restored following bath-application of the FAAH inhibitor URB597 (2 μM, 45 min preincubation, URB, n = 6; pink circle): 0.207 ± 0.017 mV before and 0.165 ± 0.007 after LTD induction (n = 6; p&lt;0.05, paired t-test). (<bold>C</bold>) The URB597 LTD rescue requires CB1R. Time course of fEPSP during 10 Hz stimulus evoked LTD (arrow, 10 min) in presence of CB1R antagonist SR141716 (SR, 4 μM, n = 8, blue circles) or TRPV1 antagonist Capsazepine (CPZ, 10 μM, n = 3, black circles) in WIN-prenatally exposed males. (<bold>D</bold>) Individual experiments: SR141716A preincubation prevented from the URB597 restoration of LTD: 0.222 ± 0.028 mV before and 0.217 ± 0.026 after LTD induction (blue circle, n = 8; p&gt;0.05, paired t-test). In contrast, the TRPV1 antagonist did not prevent from URB597 rescue: 0.214 ± 0.042 mV before LTD and 0.170 ± 0.030 mV after LTD induction (black circle, n = 3; p&lt;0.05, paired t-test). (<bold>E–F</bold>) Systemic administration of URB597 (0.1 mg/kg, i.p.) normalized the altered social behavior in male rats prenatally exposed to WIN (numbers of contacts: E: F(<sub>WIN in utero x URB</sub>)<sub>1,15</sub>=9.341. p&lt;0.05, two-way ANOVA; time interaction: F: F(<sub>WIN in utero x URB</sub>)<sub>1,15</sub>=3.421, p=0.08, two-way ANOVA). (<bold>G-H</bold>) Pre-treatment with the CB1R antagonist SR141716A (1 mg/kg, i.p.) prevented the curating actions of URB597 (0.1 mg/kg, i.p.) on social interaction. In contrast, the TRPV1 antagonist capsazepine did not block the curating effects of URB597 on social interaction in adult rats prenatally exposed to WIN55,212–2 (number of contacts: G: F<sub>3,34</sub>=21.02, p&lt;0.05, one-way ANOVA; time interaction: H: F<sub>3,34</sub>=18.34, p&lt;0.05, one-way ANOVA). Scatter dot plot represents each animal. Error bars indicate SEM. *p&lt;0.05 Student–Newman–Keuls test.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-36234-fig12-v2"/></fig></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>We discovered that fetal exposure to cannabinoids causes sex-specific alterations of behavioral and synaptic functions in the adult progeny. Specifically, we found that prenatal cannabinoid exposure (PCE) reduces social interactions in males but not females, while other behaviors were spared. In parallel, PCE specifically altered neuronal excitability and synaptic plasticity in the prefrontal cortex of male rats. We also identify a pharmacological strategy to normalize synaptic functions and socialization in adult prenatally exposed males.</p><p>PFC malfunctions are a common denominator in several neuropsychiatric diseases (<xref ref-type="bibr" rid="bib23">Goto et al., 2010</xref>; <xref ref-type="bibr" rid="bib32">Iafrati et al., 2014</xref>; <xref ref-type="bibr" rid="bib37">Kasanetz et al., 2013</xref>; <xref ref-type="bibr" rid="bib43">Labouesse et al., 2017</xref>; <xref ref-type="bibr" rid="bib45">Lafourcade et al., 2011</xref>; <xref ref-type="bibr" rid="bib50">Manduca et al., 2017</xref>; Martin et al.). Our data indicate that in the PCE group, plasticity deficits were circumscribed to eCB-LTD as two other types of synaptic plasticity, which act as biomarkers for prefrontal deficits in other model of neuropsychiatric diseases, were spared. Namely neither NMDAR-mediated LTP (<xref ref-type="bibr" rid="bib32">Iafrati et al., 2014</xref>; <xref ref-type="bibr" rid="bib50">Manduca et al., 2017</xref>; <xref ref-type="bibr" rid="bib53">Martin and Manzoni, 2014</xref>; <xref ref-type="bibr" rid="bib76">Thomazeau et al., 2017</xref>) nor mGluR2/3-LTD (<xref ref-type="bibr" rid="bib37">Kasanetz et al., 2013</xref>) were affected in PCE males. Furthermore, while excitatory synapses of the nucleus accumbens display reduced eCB-mediated plasticity in models of depression (<xref ref-type="bibr" rid="bib7">Bosch-Bouju et al., 2016</xref>), autism (<xref ref-type="bibr" rid="bib35">Jung et al., 2012</xref>), adult cannabis exposure (<xref ref-type="bibr" rid="bib59">Mato et al., 2004</xref>; <xref ref-type="bibr" rid="bib60">Mato et al., 2005</xref>) or nutritional deficits (<xref ref-type="bibr" rid="bib50">Manduca et al., 2017</xref>), accumbal eCB-LTD was normal in both PCE males and females.</p><p>Our behavioral exploration reveals that social interactions were reduced in males after PCE while female social behavior and other behavioral domains were spared in both sexes. Our results greatly extend that of Vargish and collaborators, who observed reduced social interaction in PCE mice (<xref ref-type="bibr" rid="bib80">Vargish et al., 2017</xref>). In the latter study, female progeny was unfortunately not tested. The current results add to previous work showing covariation between defects in PFC synaptic plasticity and social interaction behaviors (<xref ref-type="bibr" rid="bib50">Manduca et al., 2017</xref>). Together, these data suggest a certain level of regional PFC specificity to the effects of PCE. The fact that the PFC develops late in to postnatal life (i.e. late adolescence/early adulthood) (<xref ref-type="bibr" rid="bib1">Arain et al., 2013</xref>; <xref ref-type="bibr" rid="bib19">Fuster, 1991</xref>; <xref ref-type="bibr" rid="bib41">Kolb et al., 2012</xref>) may explain this sensitivity.</p><p>In the hippocampus, PCE impaired eCB-dependent short-term depression at GABAergic synapses (<xref ref-type="bibr" rid="bib80">Vargish et al., 2017</xref>) and NMDAR-dependent LTD (<xref ref-type="bibr" rid="bib61">Mereu et al., 2003</xref>; <xref ref-type="bibr" rid="bib77">Tortoriello et al., 2014</xref>). In contrast with the latter hippocampal study, we found no evidence that PCE modified release properties of PFC synapses, reinforcing the idea that region-specific mechanisms engage to alter PFC synapses in response to PCE. Our qRT-PCR data showed similar levels of CB1R mRNA in the PFC of male and female progeny exposed to cannabinoids during fetal life, in line with previous observations in the hippocampus and neocortex (<xref ref-type="bibr" rid="bib77">Tortoriello et al., 2014</xref>).</p><p>While our work clearly shows previously undisclosed sexual divergence in the consequences of fetal cannabinoids, they also reveal sex differences in the main elements involved in eCB signaling: CB1R was similar in both sexes while lower mRNA levels of the 2-arachidonoylglycerol (2-AG) synthesizing (DAGLα) enzyme were found in naive females compared to naive males. Previous work highlighted sexual differences at the molecular level. CB1R affinity is higher in males while receptor density is similar in both sexes in the limbic forebrain; however, in the mesencephalon both parameters are higher in males (<xref ref-type="bibr" rid="bib71">Rodríguez de Fonseca et al., 1994</xref>). In the PFC, CB1R density is lower in males than in females (<xref ref-type="bibr" rid="bib12">Castelli et al., 2014</xref>). At the structural level, the medial PFC of rats is also sexually different: female prelimbic cortex pyramidal neurons have smaller/less complex apical dendritic arbors than in males (<xref ref-type="bibr" rid="bib21">Garrett and Wellman, 2009</xref>; <xref ref-type="bibr" rid="bib42">Kolb and Stewart, 1991</xref>). Thus, it is likely that both nanoscale differences in the relative position of the molecular elements of the eCB system and dissimilarities of mRNA/protein expression underlie these sex differences. At the behavioral level, sexual differences in fear-conditioning have also been identified (<xref ref-type="bibr" rid="bib25">Gruene et al., 2015</xref>; <xref ref-type="bibr" rid="bib27">Gupta et al., 2001</xref>; <xref ref-type="bibr" rid="bib65">Pryce et al., 1999</xref>). Sexual differences are unlikely exclusive to the eCB-LTD/PFC/fear conditioning. For instance, active avoidance (<xref ref-type="bibr" rid="bib15">Dalla and Shors, 2009</xref>), spatial memory (<xref ref-type="bibr" rid="bib15">Dalla and Shors, 2009</xref>; <xref ref-type="bibr" rid="bib67">Qi et al., 2016</xref>) and hippocampal LTP (<xref ref-type="bibr" rid="bib27">Gupta et al., 2001</xref>; <xref ref-type="bibr" rid="bib51">Maren, 1995</xref>; <xref ref-type="bibr" rid="bib67">Qi et al., 2016</xref>) display sex differences. The data provide new impetus for the urgent need to investigate the functional and behavioral substrates of neuropsychiatric diseases in both sexes.</p><p>Reduced bioavailability of endocannabinoids during LTD induction likely underlies the lack of synaptic plasticity found in PCE males. In support of this idea, basal levels of anandamide are reduced in limbic areas of prenatally WIN-exposed rats (<xref ref-type="bibr" rid="bib11">Castelli et al., 2007</xref>). We hypothesized that enhancing anandamide levels may lower the LTD-induction threshold and indeed found that FAAH inhibition with URB597 restored eCB-LTD in PCE males. Furthermore, based on the well-known, prominent role of mGlu<sub>5</sub> in synaptic eCB-signaling (<xref ref-type="bibr" rid="bib2">Araque et al., 2017</xref>), we found that positive allosteric modulation of mGlu<sub>5</sub> with CDPPB (<xref ref-type="bibr" rid="bib50">Manduca et al., 2017</xref>; <xref ref-type="bibr" rid="bib55">Martin et al., 2016a</xref>) restored LTD in PCE males. Strikingly, this finding translated well from the ex vivo slice preparations to the behavioral level, and in vivo treatments with either the FAAH inhibitor or the mGlu<sub>5</sub> PAM normalized social interactions in PCE exposed adult males.</p><p>In conclusion, these results provide compelling evidences for sexual divergence in the long-term functional and behavioral consequences of PCE and introduce strategies for reversing its detrimental effects.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Animals</title><p>The experiments were performed following the ARRIVE (Animals in Research: Reporting In Vivo Experiments) guidelines (<xref ref-type="bibr" rid="bib39">Kilkenny et al., 2010</xref>). Wistar female rats (Charles River, France) weighing 250 – 280 g were housed at constant room temperature (20 ± 1°C) and humidity (60%), and exposed to a light cycle of 12 hr/day (08:00 a.m. to 08:00 p.m.), with food and water available ad libitum. For mating, pairs of females were placed with single male rat in the late afternoon. Vaginal smears were taken the following morning at 09:00 a.m. The day on which sperm was present was designated as the day 0 of gestation (GD 0).</p><p>Sub-cutaneous (s.c.) injections were performed daily with the synthetic cannabinoid WIN55,212 – 2 (WIN, 0.5 mg/kg), the phytocannabinoid Delta9-Tetrahydrocannabinol, THC (5 mg/kg) or their respective vehicles from GD 5 to GD 20. WIN was suspended in 5% DMSO, 5% cremophor and saline, at a volume of 1 ml/kg. Control dams (SHAM group) received a similar volume injection of vehicle solution. THC was suspended in 5% Ethanol, 5% cremophor and saline, and injected s.c. at a volume of 1 ml/kg. Control dams (SHAM group) received a similar volume injection of vehicle solution. Newborn litters found up to 05:00 p.m. were considered to be born on that day (postnatal day (PND) 0). On PND 21, the pups were weaned and housed in groups of three. The experiments were carried out on the male and female offspring at adulthood (PNDs 90 – 130). One pup per litter from different litters per treatment group was used in the behavioral experiments. Sample size (n and scatter dot plot) is indicated in the figure legends.</p><p>Animals were treated in compliance with the European Communities Council Directive (86/609/EEC) and the United States National Institutes of Health Guide for the care and use of laboratory animals.</p><p>Body weights of the dams were taken daily throughout pregnancy and the length of pregnancy was determined. Litter size, weight gain of pups and postnatal vitality were also measured, see <xref ref-type="table" rid="table3">Table 3</xref>.</p><table-wrap id="table3" position="float"><object-id pub-id-type="doi">10.7554/eLife.36234.021</object-id><label>Table 3.</label><caption><title>Reproduction data and pup weight after in utero WIN exposure.</title><p>Dam weight gain was calculated from GD 1 to GD 21 for n = 10 dams per treatment group. Pup weight at different postnatal days (PND) was calculated for n = 9–10 male and female pups from different litters. Data represent mean values ± SEM. Statistical significance was determined using the one-way ANOVA test.</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th rowspan="2" valign="top"/><th/><th/><th/><th rowspan="3">p-Value <break/>(ANOVA)</th></tr><tr><th/><th>Naive</th><th>SHAM</th><th>WIN</th></tr><tr><th valign="top"/><th valign="top"/><th>mean ± SEM</th><th>mean ± SEM</th><th>mean ± SEM</th></tr></thead><tbody><tr><td/><td rowspan="2">Dam weight gain (%)</td><td/><td/><td/><td/></tr><tr><td/><td>33.8 ± 0.93</td><td>34.3 ± 1.91</td><td>33.1 ± 1.42</td><td>0.745</td></tr><tr><td/><td rowspan="2">Pregnancy length (days)</td><td/><td/><td/><td/></tr><tr><td>Reproduction data</td><td>22.4 ± 0.14</td><td>22.6 ± 0.29</td><td>22.6 ± 0.17</td><td>0.923</td></tr><tr><td valign="top"/><td/><td/><td/><td/><td/></tr><tr><td valign="top"/><td>Litter size</td><td>13 ± 0.82</td><td>12.9 ± 0.78</td><td>12.7 ± 0.67</td><td>0.854</td></tr><tr><td/><td>PND 1</td><td>6.8 ± 0.2</td><td>6.7 ± 0.1</td><td>6.8 ± 0.2</td><td>0.965</td></tr><tr><td/><td>PND 10</td><td>23.5 ± 0.89</td><td>24.6 ± 0.65</td><td>22.6 ± 0.72</td><td>0.207</td></tr><tr><td>Pup weight (grams)</td><td>PND 13</td><td>31.8 ± 0.62</td><td>30.3 ± 0.82</td><td>30.5 ± 0.75</td><td>0.339</td></tr><tr><td valign="top"/><td>PND 25</td><td>64.5 ± 2.24</td><td>65.6 ± 0.77</td><td>66.7 ± 1.55</td><td>0.647</td></tr><tr><td valign="top"/><td>PND 90</td><td>452.7 ± 12.28</td><td>484.2 ± 12.52</td><td>481.7 ± 17.33</td><td>0.261</td></tr></tbody></table></table-wrap></sec><sec id="s4-2"><title>Behavior</title><sec id="s4-2-1"><title>All animals were experimentally naïve and used only once</title><p><italic>Social interaction:</italic> Social behavior was assessed as previously described (<xref ref-type="bibr" rid="bib48">Manduca et al., 2015</xref>). The test was performed in a sound attenuated chamber under dim light conditions. The testing arena consisted of a Plexiglas cage measuring 45 × 45 cm, with 2 cm of wood shavings covering the floor. Rats were individually habituated to the test cage for 5 min on each of the 2 days prior to testing. Before testing, animals were socially isolated for 24 hr to enhance their social motivation and thus facilitate the expression of social behaviors during testing.</p><p>We verified that the short period of social isolation before testing does not modify social interaction between males and females (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). Naive male and female rats not isolated before testing showed similar frequency and time of social interaction to rats isolated 24 hr prior social interaction testing (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A-B</xref>) . Detailed exploration of the various parameters of social interaction revealed that sniffing (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C-D</xref>) was unchanged and the play events were reduced only in female animals (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1E</xref>), while the number of attacks remained unchanged (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1F</xref>).</p><p>Drug treatments were counterbalanced so that cage mates were allocated to different treatment groups. The animals of each pair were similarly treated, did not differ more than 10 g in body weight and were not cage mates. Behavior was assessed per pair of animals and analyzed by a trained observer who was unaware of treatment condition using the Ethovision XT 13.0 video tracking software (Noldus, Wageningen, The Netherlands).</p><p>The test consisted of placing two similarly treated animals into the test cage for 10 min. The total frequency of active social interactions was obtained as the sum of the frequency of the following behavioral elements scored per 10 min (<xref ref-type="bibr" rid="bib48">Manduca et al., 2015</xref>; <xref ref-type="bibr" rid="bib74">Segatto et al., 2014</xref>):</p><list list-type="bullet"><list-item><p>Play-related behaviors: pouncing (on rat solicits another rat to play by attempting to nose or rub the nape of its neck), pinning (the rat that is pounced upon can respond in different ways – ‘pinning’ is the result when the animal lies with its dorsal surface on the floor with the other rat standing over it) and boxing (rats push or paw at each other with their forepaws, usually around the head, neck, shoulders of their opponent).</p></list-item><list-item><p>Social behaviors unrelated to play: social exploration (sniffing any part of the body of the test partner), social grooming (one rat licks and chews the fur of the conspecific, while placing its forepaws on the back or the neck of the other rat), following/chasing (walking or running in the direction of the partner which stays where it is or moves away), crawling under/over (one animal crawls underneath or over the partner's body, crossing it transversely from one side to the other), kicking (the rat kicks backwards at the conspecific with one or both hind paws).</p></list-item><list-item><p>Aggressive behavior: attack.</p></list-item></list></sec><sec id="s4-2-2"><title>Open field</title><p>The test was performed as we previously published (<xref ref-type="bibr" rid="bib50">Manduca et al., 2017</xref>; <xref ref-type="bibr" rid="bib35">Jung et al., 2012</xref>). The apparatus consisted of a Plexiglas arena 45 × 45 cm, illuminated by fluorescent bulbs at a height of 2 m above the floor of the open field apparatus (light intensity of 30 Lux). The floor was cleaned between each trial to avoid olfactory clues. Each animal was transferred to the open-field facing a corner and was allowed to freely explore the experimental area for 10 min. A video tracking system (Ethovision XT, Noldus Information Technology) recorded the exact track of each rat as well as total distance traveled (<xref ref-type="bibr" rid="bib45">Lafourcade et al., 2011</xref>; <xref ref-type="bibr" rid="bib46">Larrieu et al., 2012</xref>).</p></sec><sec id="s4-2-3"><title>Elevated plus-maze </title><p>The elevated plus-maze apparatus comprised two open (50 × 10 × 40 cm) and two closed arms (50 × 10 × 40 cm) that extended from a common central platform (10 × 10 cm). The test was performed as previously described (<xref ref-type="bibr" rid="bib48">Manduca et al., 2015</xref>). Rats were individually placed on the central platform of the maze for 5 min. Each 5 min session was recorded with a camera positioned above the apparatus for subsequent behavioral analysis carried out an observer, unaware of animal treatment, using the Observer 3.0 software (Noldus, The Netherlands). The following parameters were analyzed:</p><list list-type="bullet"><list-item><p>% time spent in the open arms (% Time Open): (seconds spent on the open arms of the maze/seconds spent on the open +closed arms)×100;</p></list-item><list-item><p>% open arm entries (% Open Entries): (the number of entries into the open arms of the maze/number of entries into open +closed arms)×100;</p></list-item></list></sec><sec id="s4-2-4"><title>Temporal order</title><p>Animals were habituated to the experimental arena (40 × 40 cm) without objects for 10 min daily for 2 days before testing. This task consisted of two sample phases and one test trial (<xref ref-type="bibr" rid="bib4">Barker et al., 2007</xref>). In each sample phase, rats were allowed to explore two copies of an identical object for a total of 4 min. Different objects were used for sample Phases 1 and 2, with a delay between the sample phases of 1 hr. After 3 hr from sample Phase 2, rats performed the test trial (4 min duration) where a third copy of the objects from sample Phase 1 and a third copy of the objects from sample Phase 2 were used. The positions of the objects in the test and the objects used in sample Phase 1 and sample Phase 2 were counterbalanced between the animals. An intact temporal order memory requested the subjects to spend more time exploring the object from Sample 1 (i.e. the object presented less recently) compared with the object from Sample 2 (i.e. the ‘new’ object). The discrimination ratio was calculated as the difference in time spent by each animal exploring the object from sample Phase 1 compared with the object from sample Phase 2 divided by the total time spent exploring both objects in the test phase.</p></sec><sec id="s4-2-5"><title>Novel object recognition </title><p>After 2 days of 10 min habituation to the experimental arena, rats were exposed to the procedure of an acquisition or sample phase, followed by a preference test after a delay of 30 min (<xref ref-type="bibr" rid="bib10">Campolongo et al., 2012</xref>). In the sample phase, duplicate copies (A1 and A2) of an object were placed near the two corners at either end of one side of the arena (8 cm from each adjacent wall). Rats were placed into the arena facing the center of the opposite wall and allowed a total of 4 min in the arena. At test (4 min duration), animals were placed in the arena, presented with two objects in the same positions: one object (A3) was a third copy of the set of the objects used in the sample phase, and the other object was a novel object (B). The positions of the objects in the test and the objects used as novel or familiar were counterbalanced between the rats. The discrimination ratio was calculated as the difference in time spent by each animal exploring the novel compared with the familiar object divided by the total time spent exploring both objects. Exploration was scored when the animal was observed sniffing or touching the object with the nose and/or forepaws. Sitting on objects was not considered to indicate exploratory behavior.</p></sec></sec><sec id="s4-3"><title>Drug treatment</title><p>The CB1 cannabinoid receptor antagonist SR141716A [5-(4-chloro-phenyl)−1-(2,4-dichlorophenyl)−4-methyl-N-1-piperidinyl-1H-pyrazole-3-carboxamide] (National Institute of Mental Health, USA), the positive allosteric modulator of mGlu<sub>5</sub> receptors CDPPB (3-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl) benzamide) (National Institute of Mental Health, USA), the vanilloid TRPV1 antagonist capsazepine (N-[2-(4-Chlorophenyl)ethyl]−1,3,4,5-tetrahydro-7,8-dihydroxy-2H-2-benzazepine-2-carbothioamide) (Tocris) and the FAAH inhibitor URB597 (Cyclohexylcarbamic acid 3'-(Aminocarbonyl)-[1,1'-biphenyl]−3-yl ester) (Tocris) were dissolved in 5% Tween 80/5% polyethylene glycol/saline and given intraperitoneally (i.p.). CDPPB (0.75 mg/kg) or its vehicle were administered 30 min before testing; URB597 (0.1 mg/kg) or its vehicle were administered 2 hr before testing; SR141716A was administered 30 min before CDPPB or URB597 at a dose that did not induce effects by itself (1 mg/kg) in adult rats (<xref ref-type="bibr" rid="bib48">Manduca et al., 2015</xref>; <xref ref-type="bibr" rid="bib73">Sciolino et al., 2011</xref>). Capsazepine (5 mg/kg) was injected 30 min before CDPPB and URB597. Drug doses and pre-treatment intervals were based on the literature (<xref ref-type="bibr" rid="bib48">Manduca et al., 2015</xref>; <xref ref-type="bibr" rid="bib68">Ratano et al., 2017</xref>) and on pilot experiments. Solutions were freshly prepared on the day of the experiment and were administered in a volume of 1 ml/kg.</p></sec><sec id="s4-4"><title>Physiology</title><sec id="s4-4-1"><title>Slice preparation </title><p>Adult male and female rats were anesthetized with isoflurane and killed as previously described (<xref ref-type="bibr" rid="bib53">Martin and Manzoni, 2014</xref>; <xref ref-type="bibr" rid="bib50">Manduca et al., 2017</xref>). The brain was sliced (300 μm) in the coronal plane with a vibratome (Integraslice, Campden Instruments) in a sucrose-based solution at 4°C (in mm as follows: 87 NaCl, 75 sucrose, 25 glucose, 2.5 KCl, 4 MgCl2, 0.5 CaCl<sub>2</sub>, 23 NaHCO<sub>3</sub> and 1.25 NaH<sub>2</sub>PO<sub>4</sub>). Immediately after cutting, slices containing the medial prefrontal cortex (PFC) or accumbens were stored for 1 hr at 32°C in a low-calcium ACSF that contained (in mm) as follows: 130 NaCl, 11 glucose, 2.5 KCl, 2.4 MgCl<sub>2</sub>, 1.2 CaCl<sub>2</sub>, 23 NaHCO<sub>3</sub>, 1.2 NaH<sub>2</sub>PO<sub>4</sub>, and were equilibrated with 95% O2/5% CO2 and then at room temperature until the time of recording. During the recording, slices were placed in the recording chamber and superfused at 2 ml/min with either low Ca<sup>2+</sup> ACSF for mPFC or normal ACSF for the accumbens. All experiments were done at 32°C or room temperature for mPFC and accumbens respectively. The superfusion medium contained picrotoxin (100 µM) to block gamma-aminobutyric acid types A (GABA-A) receptors. All drugs were added at the final concentration to the superfusion medium.</p></sec><sec id="s4-4-2"><title>Electrophysiology</title><p>Whole cell patch-clamp of visualized layer five pyramidal neurons mPFC and field potential recordings were made in coronal slices containing the mPFC or the accumbens as previously described (<xref ref-type="bibr" rid="bib38">Kasanetz and Manzoni, 2009</xref>; <xref ref-type="bibr" rid="bib36">Kasanetz et al., 2010</xref>; <xref ref-type="bibr" rid="bib37">Kasanetz et al., 2013</xref>). Neurons were visualized using an upright microscope with infrared illumination. The intracellular solution was based on K<sup>+</sup> gluconate (in mM: 145 K<sup>+</sup> gluconate, 3 NaCl, 1 MgCl<sub>2</sub>, 1 EGTA, 0.3 CaCl<sub>2</sub>, 2 Na<sub>2</sub><sup>+</sup>ATP, and 0.3 Na<sup>+</sup> GTP, 0.2 cAMP, buffered with 10 HEPES). To quantify the AMPA/NMDA ratio we used a CH<sub>3</sub>O<sub>3</sub>SCs-based solution (in mM: 128 CH<sub>3</sub>O<sub>3</sub>SCs, 20 NaCl, 1 MgCl<sub>2</sub>, 1 EGTA, 0.3 CaCl<sub>2</sub>, 2 Na<sub>2</sub><sup>+</sup>ATP, and 0.3 Na<sup>+</sup> GTP, 0.2 cAMP, buffered with 10 HEPES, pH 7.2, osmolarity 290 – 300 mOsm). The pH was adjusted to 7.2 and osmolarity to 290 – 300 mOsm. Electrode resistance was 4 – 6 MOhms.</p><p>Whole cell patch-clamp recordings were performed with an Axopatch-200B amplifier as previously described (<xref ref-type="bibr" rid="bib35">Jung et al., 2012</xref>; <xref ref-type="bibr" rid="bib38">Kasanetz and Manzoni, 2009</xref>; <xref ref-type="bibr" rid="bib45">Lafourcade et al., 2011</xref>; <xref ref-type="bibr" rid="bib50">Manduca et al., 2017</xref>; <xref ref-type="bibr" rid="bib56">Martin et al., 2016b</xref>;; <xref ref-type="bibr" rid="bib55">Martin et al., 2016a</xref>; <xref ref-type="bibr" rid="bib69">Robbe et al., 2002a</xref>; <xref ref-type="bibr" rid="bib70">Robbe et al., 2002b</xref>; <xref ref-type="bibr" rid="bib75">Thomazeau et al., 2014</xref>; <xref ref-type="bibr" rid="bib76">Thomazeau et al., 2017</xref>). Data were low-pass filtered at 2 kHz, digitized (10 kHz, DigiData 1440A, Axon Instrument), collected using Clampex 10.2 and analyzed using Clampfit 10.2 (all from Molecular Device, Sunnyvale, USA).</p><p>A −2 mV hyperpolarizing pulse was applied before each evoked EPSC in order to evaluate the access resistance and those experiments in which this parameter changed &gt;25% were rejected. Access resistance compensation was not used, and acceptable access resistance was &lt;30 MOhms. The potential reference of the amplifier was adjusted to zero prior to breaking into the cell. Cells were held at −76 mV.</p><p><italic>Current-voltage (I-V) curves</italic> were made by a series of hyperpolarizing to depolarizing current steps immediately after breaking into the cell. Membrane resistance was estimated from the I–V curve around resting membrane potential (<xref ref-type="bibr" rid="bib36">Kasanetz et al., 2010</xref>; <xref ref-type="bibr" rid="bib54">Martin et al., 2015</xref>).</p><p><italic>Field potential recordings</italic> were made in coronal slices containing the mPFC or the accumbens as previously described (<xref ref-type="bibr" rid="bib38">Kasanetz and Manzoni, 2009</xref>; <xref ref-type="bibr" rid="bib36">Kasanetz et al., 2010</xref>; <xref ref-type="bibr" rid="bib37">Kasanetz et al., 2013</xref>). During the recording, slices were placed in the recording chamber and superfused at 2 ml/min with either low Ca<sup>2+</sup> ACSF for mPFC or normal ACSF for the accumbens. All experiments were done at 32°C or room temperature for mPFC and accumbens, respectively. The superfusion medium contained picrotoxin (100 μM) to block GABA Type A (GABA-A) receptors. All drugs were added at the final concentration to the superfusion medium. The glutamatergic nature of the field EPSP (fEPSP) was systematically confirmed at the end of the experiments using the ionotropic glutamate receptor antagonist CNQX (20 μM), which specifically blocked the synaptic component without altering the non-synaptic component (data not shown).</p><p>Both fEPSP area and amplitude were analyzed. Stimulation was performed with a glass electrode filled with ACSF and the stimulus intensity was adjusted ∼60% of maximal intensity after performing an input–output curve (baseline EPSC amplitudes ranged between 50 and 150 pA). Stimulation frequency was set at 0.1 Hz.</p></sec><sec id="s4-4-3"><title>Data acquisition and analysis</title><p> The magnitude of plasticity was calculated 35–40 min after induction as percentage of baseline responses. Statistical analysis of data was performed with Prism (GraphPad Software) using tests indicated in the main text after outlier subtraction. All values are given as mean ±SEM, and statistical significance was set at p&lt;0.05.</p></sec><sec id="s4-4-4"><title>Biochemistry <italic>qRT-PCR</italic></title><p>Frozen rat brains were coronally sectioned in a cutting block (Braintree Scientific, Inc., Braintree, MA, Cat.# BS-SS 605C) that had been pre-chilled to −20°C. One-millimeter sections were kept frozen throughout dissection with brain regions stored at −80°C until use. Total RNA was extracted using the RNeasy Plus Micro Kit (Qiagen, Hilden, Germany, Cat.# 74034). RNA was reverse-transcribed using the RevertAid Kit (Thermo Fisher Scientific, Waltham, MA Cat.# K1621) as per manufacturer’s instructions. Taqman primers and probes were obtained through Applied Biosystems. Sequences used in qRT-PCR are as follows:</p><p><table-wrap id="inlinetable1" position="anchor"><table frame="hsides" rules="groups"><thead><tr><th valign="bottom"/><th valign="bottom">Sense</th><th valign="bottom">Anti-Sense</th><th valign="bottom">Probe</th><th valign="bottom">Fluorophore</th><th valign="bottom">Quencher</th></tr></thead><tbody><tr><td>CB1</td><td valign="bottom">tttcaagcaaggagcaccca</td><td valign="bottom">ggtacggaaggtggtgtctg</td><td valign="bottom">ctttctcagtcaccttgagtctggcct</td><td valign="bottom">FAM</td><td valign="bottom">Qsys</td></tr><tr><td>CB2</td><td valign="bottom">ccacgccgtgcctgagtgag</td><td valign="bottom">ccgccattggagccgttggt</td><td valign="bottom">cgaggccacccagcaaacatct</td><td valign="bottom">FAM</td><td valign="bottom">Qsys</td></tr><tr><td>DAGLalpha</td><td valign="bottom">gggtctgaaaccaaacacgc</td><td valign="bottom">gacacagtggggagttggag</td><td valign="bottom">ctgcccacttgctctcctggc</td><td valign="bottom">FAM</td><td valign="bottom">Qsys</td></tr><tr><td>DAGL-beta</td><td valign="bottom">tacggatggcccctctacat</td><td valign="bottom">gctcgtacaccttgtcgtga</td><td valign="bottom">agcaccactgccacttcgcc</td><td valign="bottom">FAM</td><td valign="bottom">Qsys</td></tr><tr><td>MAGL</td><td valign="bottom">ccccttcaggggtgtgttctg</td><td valign="bottom">ctttgggccctgtttccattagtc</td><td valign="bottom">actcgaggctgtggcggtagt</td><td valign="bottom">FAM</td><td valign="bottom">Qsys</td></tr><tr><td>FAAH</td><td valign="bottom">gttcaccttggaccctaccg</td><td valign="bottom">agaagggaatcagcgtgtgg</td><td valign="bottom">accatgcccagcccagctatga</td><td valign="bottom">FAM</td><td valign="bottom">Qsys</td></tr><tr><td>NAPE-PLD</td><td valign="bottom">ctgcgtgcagctgttactgtc</td><td valign="bottom">atgtctttccgtgggaagcttga</td><td valign="bottom">caggccctccggtgaggagac</td><td valign="bottom">FAM</td><td valign="bottom">Qsys</td></tr><tr><td>TRPV1</td><td valign="bottom">cctagctggttgcaaattggg</td><td valign="bottom">tggaggtggcttgcagttag</td><td valign="bottom">ccaccccaagagaactcctgcct</td><td valign="bottom">FAM</td><td valign="bottom">Qsys</td></tr><tr><td>mGluR5</td><td valign="bottom">agacggcaaatcatcgtccg</td><td valign="bottom">ttttccgttggagcttagggtt</td><td valign="bottom">tgccagcagatccagcagccta</td><td valign="bottom">FAM</td><td valign="bottom">Qsys</td></tr><tr><td>mGluR1</td><td valign="bottom">ggatgctcccggaaggtatg</td><td valign="bottom">tcagcactccttcatgccag</td><td valign="bottom">tctgcagtacacagaagctaatcgc</td><td valign="bottom">FAM</td><td valign="bottom">Qsys</td></tr><tr><td>CRIP1a</td><td valign="bottom">aacactgcaggtcgagaaca</td><td valign="bottom">tgatctggatgggttgtcgc</td><td valign="bottom">tggtgtgcttgtcccactgga</td><td valign="bottom">FAM</td><td valign="bottom">Qsys</td></tr><tr><td>ABHD6</td><td valign="bottom">cctcggccactgaggtgtc</td><td valign="bottom">gaagctacgaaggccaggat</td><td valign="bottom">tgtgattgcgggtgggaccct</td><td valign="bottom">FAM</td><td valign="bottom">Qsys</td></tr><tr><td>KCC2</td><td valign="bottom">ccatctacgcaggggtcatc</td><td valign="bottom">ggcgggaggaacagaatagg</td><td valign="bottom">tttgcctcctggggaaccgc</td><td valign="bottom">FAM</td><td valign="bottom">Qsys</td></tr><tr><td valign="bottom">GAPDH</td><td valign="bottom">gacttcaacagcaactcccat</td><td valign="bottom">tcttgctctcagtatccttgct</td><td valign="bottom">agaaaccctggaccacccagcc</td><td valign="bottom">Vic</td><td valign="bottom">Qsys</td></tr></tbody></table></table-wrap></p><p>TaqMan Gene Expression Master Mix from Applied Biosystems (Foster City, CA Cat.# 4369016) was used in generating expression data on a QuantStudio7 thermal cycler. Duplicates were run for each sample, and changes in gene expression were determined using the ΔΔCt method. Data was analyzed using Excel (Microsoft, Redmond, WA) and Prism 7 (Graphpad, La Jolla, CA) software.</p></sec></sec><sec id="s4-5"><title>Statistics</title><p>All the behavioral parameters were expressed as mean ± SEM. Group comparisons used t-test and two-way repeated measures (RM) ANOVA (for different sex and pharmacological treatments), followed by Student-Newman-Keuls post-hoc tests when appropriate.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>The authors are grateful to Mr. Clément Bouille for experimental help, Drs. Pascale Chavis and Andrew Scheyer for helpful discussions and to the National Institute of Mental Health’s Chemical Synthesis and Drug Supply Program (Rockville, MD, USA) for providing CNQX, CDPPB, URB597 and SR141716A.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf2"><p>Reviewing editor, <italic>eLife</italic></p></fn><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Data curation, Formal analysis, Validation, Investigation, Writing—original draft</p></fn><fn fn-type="con" id="con2"><p>Data curation, Formal analysis, Validation, Investigation, Writing—original draft</p></fn><fn fn-type="con" id="con3"><p>Conceptualization, Data curation, Formal analysis, Validation</p></fn><fn fn-type="con" id="con4"><p>Data curation, Formal analysis, Validation, Writing—review and editing</p></fn><fn fn-type="con" id="con5"><p>Data curation, Formal analysis, Methodology</p></fn><fn fn-type="con" id="con6"><p>Data curation, Formal analysis, Validation, Methodology</p></fn><fn fn-type="con" id="con7"><p>Data curation, Formal analysis, Methodology</p></fn><fn fn-type="con" id="con8"><p>Data curation, Formal analysis, Methodology</p></fn><fn fn-type="con" id="con9"><p>Conceptualization, Supervision, Funding acquisition, Methodology, Writing—review and editing</p></fn><fn fn-type="con" id="con10"><p>Conceptualization, Supervision, Funding acquisition, Project administration, Writing—review and editing</p></fn><fn fn-type="con" id="con11"><p>Data curation, Formal analysis, Supervision, Validation, Investigation, Methodology, Writing—review and editing</p></fn><fn fn-type="con" id="con12"><p>Conceptualization, Supervision, Funding acquisition, Methodology, Writing—original draft, Project administration, Writing—review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: Animals were treated in compliance with the European Communities Council Directive (86/609/EEC) and the United States National Institutes of Health Guide for the care and use of laboratory animals.</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="transrepform"><object-id pub-id-type="doi">10.7554/eLife.36234.022</object-id><label>Transparent reporting form</label><media mime-subtype="pdf" mimetype="application" xlink:href="elife-36234-transrepform-v2.pdf"/></supplementary-material><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>The datasets generated during the course of our study will be available upon request to researchers for purposes of reproducing the results or replicating the procedure. Alternatively, processed data can be provided, i.e. numerical data currently represented as a graph in a figure or table.</p></sec></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arain</surname> <given-names>M</given-names></name><name><surname>Haque</surname> <given-names>M</given-names></name><name><surname>Johal</surname> <given-names>L</given-names></name><name><surname>Mathur</surname> <given-names>P</given-names></name><name><surname>Nel</surname> <given-names>W</given-names></name><name><surname>Rais</surname> <given-names>A</given-names></name><name><surname>Sandhu</surname> <given-names>R</given-names></name><name><surname>Sharma</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Maturation of the adolescent brain</article-title><source>Neuropsychiatric Disease and Treatment</source><volume>9</volume><fpage>449</fpage><lpage>461</lpage><pub-id pub-id-type="doi">10.2147/NDT.S39776</pub-id><pub-id pub-id-type="pmid">23579318</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Araque</surname> <given-names>A</given-names></name><name><surname>Castillo</surname> <given-names>PE</given-names></name><name><surname>Manzoni</surname> <given-names>OJ</given-names></name><name><surname>Tonini</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Synaptic functions of endocannabinoid signaling in health and disease</article-title><source>Neuropharmacology</source><volume>124</volume><fpage>13</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1016/j.neuropharm.2017.06.017</pub-id><pub-id pub-id-type="pmid">28625718</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bacci</surname> <given-names>A</given-names></name><name><surname>Huguenard</surname> <given-names>JR</given-names></name><name><surname>Prince</surname> <given-names>DA</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Modulation of neocortical interneurons: extrinsic influences and exercises in self-control</article-title><source>Trends in Neurosciences</source><volume>28</volume><fpage>602</fpage><lpage>610</lpage><pub-id pub-id-type="doi">10.1016/j.tins.2005.08.007</pub-id><pub-id pub-id-type="pmid">16139371</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barker</surname> <given-names>GR</given-names></name><name><surname>Bird</surname> <given-names>F</given-names></name><name><surname>Alexander</surname> <given-names>V</given-names></name><name><surname>Warburton</surname> <given-names>EC</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Recognition memory for objects, place, and temporal order: a disconnection analysis of the role of the medial prefrontal cortex and perirhinal cortex</article-title><source>Journal of Neuroscience</source><volume>27</volume><fpage>2948</fpage><lpage>2957</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.5289-06.2007</pub-id><pub-id pub-id-type="pmid">17360918</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bender</surname> <given-names>VA</given-names></name><name><surname>Bender</surname> <given-names>KJ</given-names></name><name><surname>Brasier</surname> <given-names>DJ</given-names></name><name><surname>Feldman</surname> <given-names>DE</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Two coincidence detectors for spike timing-dependent plasticity in somatosensory cortex</article-title><source>Journal of Neuroscience</source><volume>26</volume><fpage>4166</fpage><lpage>4177</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0176-06.2006</pub-id><pub-id pub-id-type="pmid">16624937</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berghuis</surname> <given-names>P</given-names></name><name><surname>Rajnicek</surname> <given-names>AM</given-names></name><name><surname>Morozov</surname> <given-names>YM</given-names></name><name><surname>Ross</surname> <given-names>RA</given-names></name><name><surname>Mulder</surname> <given-names>J</given-names></name><name><surname>Urbán</surname> <given-names>GM</given-names></name><name><surname>Monory</surname> <given-names>K</given-names></name><name><surname>Marsicano</surname> <given-names>G</given-names></name><name><surname>Matteoli</surname> <given-names>M</given-names></name><name><surname>Canty</surname> <given-names>A</given-names></name><name><surname>Irving</surname> <given-names>AJ</given-names></name><name><surname>Katona</surname> <given-names>I</given-names></name><name><surname>Yanagawa</surname> <given-names>Y</given-names></name><name><surname>Rakic</surname> <given-names>P</given-names></name><name><surname>Lutz</surname> <given-names>B</given-names></name><name><surname>Mackie</surname> <given-names>K</given-names></name><name><surname>Harkany</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Hardwiring the brain: endocannabinoids shape neuronal connectivity</article-title><source>Science</source><volume>316</volume><fpage>1212</fpage><lpage>1216</lpage><pub-id pub-id-type="doi">10.1126/science.1137406</pub-id><pub-id pub-id-type="pmid">17525344</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bosch-Bouju</surname> <given-names>C</given-names></name><name><surname>Larrieu</surname> <given-names>T</given-names></name><name><surname>Linders</surname> <given-names>L</given-names></name><name><surname>Manzoni</surname> <given-names>OJ</given-names></name><name><surname>Layé</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Endocannabinoid-Mediated plasticity in nucleus accumbens controls vulnerability to anxiety after social defeat stress</article-title><source>Cell Reports</source><volume>16</volume><fpage>1237</fpage><lpage>1242</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2016.06.082</pub-id><pub-id pub-id-type="pmid">27452462</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname> <given-names>QL</given-names></name><name><surname>Sarvet</surname> <given-names>AL</given-names></name><name><surname>Shmulewitz</surname> <given-names>D</given-names></name><name><surname>Martins</surname> <given-names>SS</given-names></name><name><surname>Wall</surname> <given-names>MM</given-names></name><name><surname>Hasin</surname> <given-names>DS</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Trends in marijuana use among pregnant and nonpregnant Reproductive-Aged women, 2002-2014</article-title><source>Jama</source><volume>317</volume><fpage>207</fpage><lpage>209</lpage><pub-id pub-id-type="doi">10.1001/jama.2016.17383</pub-id><pub-id pub-id-type="pmid">27992619</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campolongo</surname> <given-names>P</given-names></name><name><surname>Trezza</surname> <given-names>V</given-names></name><name><surname>Ratano</surname> <given-names>P</given-names></name><name><surname>Palmery</surname> <given-names>M</given-names></name><name><surname>Cuomo</surname> <given-names>V</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Developmental consequences of perinatal cannabis exposure: behavioral and neuroendocrine effects in adult rodents</article-title><source>Psychopharmacology</source><volume>214</volume><fpage>5</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1007/s00213-010-1892-x</pub-id><pub-id pub-id-type="pmid">20556598</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campolongo</surname> <given-names>P</given-names></name><name><surname>Ratano</surname> <given-names>P</given-names></name><name><surname>Manduca</surname> <given-names>A</given-names></name><name><surname>Scattoni</surname> <given-names>ML</given-names></name><name><surname>Palmery</surname> <given-names>M</given-names></name><name><surname>Trezza</surname> <given-names>V</given-names></name><name><surname>Cuomo</surname> <given-names>V</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The endocannabinoid transport inhibitor AM404 differentially modulates recognition memory in rats depending on environmental aversiveness</article-title><source>Frontiers in Behavioral Neuroscience</source><volume>6</volume><elocation-id>11</elocation-id><pub-id pub-id-type="doi">10.3389/fnbeh.2012.00011</pub-id><pub-id pub-id-type="pmid">22454620</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castelli</surname> <given-names>MP</given-names></name><name><surname>Paola Piras</surname> <given-names>A</given-names></name><name><surname>D'Agostino</surname> <given-names>A</given-names></name><name><surname>Pibiri</surname> <given-names>F</given-names></name><name><surname>Perra</surname> <given-names>S</given-names></name><name><surname>Gessa</surname> <given-names>GL</given-names></name><name><surname>Maccarrone</surname> <given-names>M</given-names></name><name><surname>Pistis</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2</article-title><source>European Journal of Pharmacology</source><volume>573</volume><fpage>11</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1016/j.ejphar.2007.06.047</pub-id><pub-id pub-id-type="pmid">17644084</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castelli</surname> <given-names>MP</given-names></name><name><surname>Fadda</surname> <given-names>P</given-names></name><name><surname>Casu</surname> <given-names>A</given-names></name><name><surname>Spano</surname> <given-names>MS</given-names></name><name><surname>Casti</surname> <given-names>A</given-names></name><name><surname>Fratta</surname> <given-names>W</given-names></name><name><surname>Fattore</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Male and female rats differ in brain cannabinoid CB1 receptor density and function and in behavioural traits predisposing to drug addiction: effect of ovarian hormones</article-title><source>Current pharmaceutical design</source><volume>20</volume><fpage>2100</fpage><lpage>2113</lpage><pub-id pub-id-type="doi">10.2174/13816128113199990430</pub-id><pub-id pub-id-type="pmid">23829370</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chávez</surname> <given-names>AE</given-names></name><name><surname>Chiu</surname> <given-names>CQ</given-names></name><name><surname>Castillo</surname> <given-names>PE</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>TRPV1 activation by endogenous anandamide triggers postsynaptic long-term depression in dentate gyrus</article-title><source>Nature Neuroscience</source><volume>13</volume><fpage>1511</fpage><lpage>1518</lpage><pub-id pub-id-type="doi">10.1038/nn.2684</pub-id><pub-id pub-id-type="pmid">21076423</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chevaleyre</surname> <given-names>V</given-names></name><name><surname>Takahashi</surname> <given-names>KA</given-names></name><name><surname>Castillo</surname> <given-names>PE</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Endocannabinoid-mediated synaptic plasticity in the CNS</article-title><source>Annual Review of Neuroscience</source><volume>29</volume><fpage>37</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1146/annurev.neuro.29.051605.112834</pub-id><pub-id pub-id-type="pmid">16776579</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dalla</surname> <given-names>C</given-names></name><name><surname>Shors</surname> <given-names>TJ</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Sex differences in learning processes of classical and operant conditioning</article-title><source>Physiology &amp; Behavior</source><volume>97</volume><fpage>229</fpage><lpage>238</lpage><pub-id pub-id-type="doi">10.1016/j.physbeh.2009.02.035</pub-id><pub-id pub-id-type="pmid">19272397</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Debanne</surname> <given-names>D</given-names></name><name><surname>Poo</surname> <given-names>MM</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Spike-timing dependent plasticity beyond synapse - pre- and post-synaptic plasticity of intrinsic neuronal excitability</article-title><source>Frontiers in Synaptic Neuroscience</source><volume>2</volume><elocation-id>21</elocation-id><pub-id pub-id-type="doi">10.3389/fnsyn.2010.00021</pub-id><pub-id pub-id-type="pmid">21423507</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Marzo</surname> <given-names>V</given-names></name><name><surname>De Petrocellis</surname> <given-names>L</given-names></name><name><surname>Fezza</surname> <given-names>F</given-names></name><name><surname>Ligresti</surname> <given-names>A</given-names></name><name><surname>Bisogno</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Anandamide receptors</article-title><source>Prostaglandins, Leukotrienes and Essential Fatty Acids</source><volume>66</volume><fpage>377</fpage><lpage>391</lpage><pub-id pub-id-type="doi">10.1054/plef.2001.0349</pub-id><pub-id pub-id-type="pmid">12052051</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Floresco</surname> <given-names>SB</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The nucleus accumbens: an interface between cognition, emotion, and action</article-title><source>Annual Review of Psychology</source><volume>66</volume><fpage>25</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1146/annurev-psych-010213-115159</pub-id><pub-id pub-id-type="pmid">25251489</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fuster</surname> <given-names>JM</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>The prefrontal cortex and its relation to behavior</article-title><source>Progress in Brain Research</source><volume>87</volume><fpage>201</fpage><lpage>211</lpage><pub-id pub-id-type="doi">10.1016/S0079-6123(08)63053-8</pub-id><pub-id pub-id-type="pmid">1907745</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia</surname> <given-names>DE</given-names></name><name><surname>Brown</surname> <given-names>S</given-names></name><name><surname>Hille</surname> <given-names>B</given-names></name><name><surname>Mackie</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Protein kinase C disrupts cannabinoid actions by phosphorylation of the CB1 cannabinoid receptor</article-title><source>The Journal of Neuroscience</source><volume>18</volume><fpage>2834</fpage><lpage>2841</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.18-08-02834.1998</pub-id><pub-id pub-id-type="pmid">9526000</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garrett</surname> <given-names>JE</given-names></name><name><surname>Wellman</surname> <given-names>CL</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Chronic stress effects on dendritic morphology in medial prefrontal cortex: sex differences and estrogen dependence</article-title><source>Neuroscience</source><volume>162</volume><fpage>195</fpage><lpage>207</lpage><pub-id pub-id-type="doi">10.1016/j.neuroscience.2009.04.057</pub-id><pub-id pub-id-type="pmid">19401219</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerdeman</surname> <given-names>GL</given-names></name><name><surname>Ronesi</surname> <given-names>J</given-names></name><name><surname>Lovinger</surname> <given-names>DM</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Postsynaptic endocannabinoid release is critical to long-term depression in the striatum</article-title><source>Nature Neuroscience</source><volume>5</volume><fpage>446</fpage><lpage>451</lpage><pub-id pub-id-type="doi">10.1038/nn832</pub-id><pub-id pub-id-type="pmid">11976704</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goto</surname> <given-names>Y</given-names></name><name><surname>Yang</surname> <given-names>CR</given-names></name><name><surname>Otani</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Functional and dysfunctional synaptic plasticity in prefrontal cortex: roles in psychiatric disorders</article-title><source>Biological Psychiatry</source><volume>67</volume><fpage>199</fpage><lpage>207</lpage><pub-id pub-id-type="doi">10.1016/j.biopsych.2009.08.026</pub-id><pub-id pub-id-type="pmid">19833323</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grant</surname> <given-names>KS</given-names></name><name><surname>Petroff</surname> <given-names>R</given-names></name><name><surname>Isoherranen</surname> <given-names>N</given-names></name><name><surname>Stella</surname> <given-names>N</given-names></name><name><surname>Burbacher</surname> <given-names>TM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Cannabis use during pregnancy: Pharmacokinetics and effects on child development</article-title><source>Pharmacology &amp; therapeutics</source><volume>182</volume><pub-id pub-id-type="doi">10.1016/j.pharmthera.2017.08.014</pub-id><pub-id pub-id-type="pmid">28847562</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gruene</surname> <given-names>TM</given-names></name><name><surname>Flick</surname> <given-names>K</given-names></name><name><surname>Stefano</surname> <given-names>A</given-names></name><name><surname>Shea</surname> <given-names>SD</given-names></name><name><surname>Shansky</surname> <given-names>RM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Sexually divergent expression of active and passive conditioned fear responses in rats</article-title><source>eLife</source><volume>4</volume><elocation-id>e11352</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.11352</pub-id><pub-id pub-id-type="pmid">26568307</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grueter</surname> <given-names>BA</given-names></name><name><surname>Brasnjo</surname> <given-names>G</given-names></name><name><surname>Malenka</surname> <given-names>RC</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Postsynaptic TRPV1 triggers cell type-specific long-term depression in the nucleus accumbens</article-title><source>Nature Neuroscience</source><volume>13</volume><fpage>1519</fpage><lpage>1525</lpage><pub-id pub-id-type="doi">10.1038/nn.2685</pub-id><pub-id pub-id-type="pmid">21076424</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname> <given-names>RR</given-names></name><name><surname>Sen</surname> <given-names>S</given-names></name><name><surname>Diepenhorst</surname> <given-names>LL</given-names></name><name><surname>Rudick</surname> <given-names>CN</given-names></name><name><surname>Maren</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Estrogen modulates sexually dimorphic contextual fear conditioning and hippocampal long-term potentiation (LTP) in rats(1)</article-title><source>Brain Research</source><volume>888</volume><fpage>356</fpage><lpage>365</lpage><pub-id pub-id-type="doi">10.1016/S0006-8993(00)03116-4</pub-id><pub-id pub-id-type="pmid">11150498</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harkany</surname> <given-names>T</given-names></name><name><surname>Guzmán</surname> <given-names>M</given-names></name><name><surname>Galve-Roperh</surname> <given-names>I</given-names></name><name><surname>Berghuis</surname> <given-names>P</given-names></name><name><surname>Devi</surname> <given-names>LA</given-names></name><name><surname>Mackie</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>The emerging functions of endocannabinoid signaling during CNS development</article-title><source>Trends in Pharmacological Sciences</source><volume>28</volume><fpage>83</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1016/j.tips.2006.12.004</pub-id><pub-id pub-id-type="pmid">17222464</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Higuera-Matas</surname> <given-names>A</given-names></name><name><surname>Ucha</surname> <given-names>M</given-names></name><name><surname>Ambrosio</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Long-term consequences of perinatal and adolescent cannabinoid exposure on neural and psychological processes</article-title><source>Neuroscience &amp; Biobehavioral Reviews</source><volume>55</volume><fpage>119</fpage><lpage>146</lpage><pub-id pub-id-type="doi">10.1016/j.neubiorev.2015.04.020</pub-id><pub-id pub-id-type="pmid">25960036</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hurd</surname> <given-names>YL</given-names></name><name><surname>Wang</surname> <given-names>X</given-names></name><name><surname>Anderson</surname> <given-names>V</given-names></name><name><surname>Beck</surname> <given-names>O</given-names></name><name><surname>Minkoff</surname> <given-names>H</given-names></name><name><surname>Dow-Edwards</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Marijuana impairs growth in mid-gestation fetuses</article-title><source>Neurotoxicology and Teratology</source><volume>27</volume><fpage>221</fpage><lpage>229</lpage><pub-id pub-id-type="doi">10.1016/j.ntt.2004.11.002</pub-id><pub-id pub-id-type="pmid">15734273</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hutchings</surname> <given-names>DE</given-names></name><name><surname>Martin</surname> <given-names>BR</given-names></name><name><surname>Gamagaris</surname> <given-names>Z</given-names></name><name><surname>Miller</surname> <given-names>N</given-names></name><name><surname>Fico</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="1989">1989</year><article-title>Plasma concentrations of delta-9-tetrahydrocannabinol in dams and fetuses following acute or multiple prenatal dosing in rats</article-title><source>Life Sciences</source><volume>44</volume><fpage>697</fpage><lpage>701</lpage><pub-id pub-id-type="doi">10.1016/0024-3205(89)90380-9</pub-id><pub-id pub-id-type="pmid">2538691</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iafrati</surname> <given-names>J</given-names></name><name><surname>Orejarena</surname> <given-names>MJ</given-names></name><name><surname>Lassalle</surname> <given-names>O</given-names></name><name><surname>Bouamrane</surname> <given-names>L</given-names></name><name><surname>Gonzalez-Campo</surname> <given-names>C</given-names></name><name><surname>Chavis</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Reelin, an extracellular matrix protein linked to early onset psychiatric diseases, drives postnatal development of the prefrontal cortex via GluN2B-NMDARs and the mTOR pathway</article-title><source>Molecular Psychiatry</source><volume>19</volume><fpage>417</fpage><lpage>426</lpage><pub-id pub-id-type="doi">10.1038/mp.2013.66</pub-id><pub-id pub-id-type="pmid">23752244</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iafrati</surname> <given-names>J</given-names></name><name><surname>Malvache</surname> <given-names>A</given-names></name><name><surname>Gonzalez Campo</surname> <given-names>C</given-names></name><name><surname>Orejarena</surname> <given-names>MJ</given-names></name><name><surname>Lassalle</surname> <given-names>O</given-names></name><name><surname>Bouamrane</surname> <given-names>L</given-names></name><name><surname>Chavis</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Multivariate synaptic and behavioral profiling reveals new developmental endophenotypes in the prefrontal cortex</article-title><source>Scientific Reports</source><volume>6</volume><elocation-id>35504</elocation-id><pub-id pub-id-type="doi">10.1038/srep35504</pub-id><pub-id pub-id-type="pmid">27765946</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iremonger</surname> <given-names>KJ</given-names></name><name><surname>Kuzmiski</surname> <given-names>JB</given-names></name><name><surname>Baimoukhametova</surname> <given-names>DV</given-names></name><name><surname>Bains</surname> <given-names>JS</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Dual regulation of anterograde and retrograde transmission by endocannabinoids</article-title><source>Journal of Neuroscience</source><volume>31</volume><fpage>12011</fpage><lpage>12020</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2925-11.2011</pub-id><pub-id pub-id-type="pmid">21849561</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jung</surname> <given-names>K-M</given-names></name><name><surname>Sepers</surname> <given-names>M</given-names></name><name><surname>Henstridge</surname> <given-names>CM</given-names></name><name><surname>Lassalle</surname> <given-names>O</given-names></name><name><surname>Neuhofer</surname> <given-names>D</given-names></name><name><surname>Martin</surname> <given-names>H</given-names></name><name><surname>Ginger</surname> <given-names>M</given-names></name><name><surname>Frick</surname> <given-names>A</given-names></name><name><surname>DiPatrizio</surname> <given-names>NV</given-names></name><name><surname>Mackie</surname> <given-names>K</given-names></name><name><surname>Katona</surname> <given-names>I</given-names></name><name><surname>Piomelli</surname> <given-names>D</given-names></name><name><surname>Manzoni</surname> <given-names>OJ</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Uncoupling of the endocannabinoid signalling complex in a mouse model of fragile X syndrome</article-title><source>Nature Communications</source><volume>3</volume><elocation-id>ncomms2045</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms2045</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kasanetz</surname> <given-names>F</given-names></name><name><surname>Deroche-Gamonet</surname> <given-names>V</given-names></name><name><surname>Berson</surname> <given-names>N</given-names></name><name><surname>Balado</surname> <given-names>E</given-names></name><name><surname>Lafourcade</surname> <given-names>M</given-names></name><name><surname>Manzoni</surname> <given-names>O</given-names></name><name><surname>Piazza</surname> <given-names>PV</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Transition to addiction is associated with a persistent impairment in synaptic plasticity</article-title><source>Science</source><volume>328</volume><fpage>1709</fpage><lpage>1712</lpage><pub-id pub-id-type="doi">10.1126/science.1187801</pub-id><pub-id pub-id-type="pmid">20576893</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kasanetz</surname> <given-names>F</given-names></name><name><surname>Lafourcade</surname> <given-names>M</given-names></name><name><surname>Deroche-Gamonet</surname> <given-names>V</given-names></name><name><surname>Revest</surname> <given-names>JM</given-names></name><name><surname>Berson</surname> <given-names>N</given-names></name><name><surname>Balado</surname> <given-names>E</given-names></name><name><surname>Fiancette</surname> <given-names>JF</given-names></name><name><surname>Renault</surname> <given-names>P</given-names></name><name><surname>Piazza</surname> <given-names>PV</given-names></name><name><surname>Manzoni</surname> <given-names>OJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Prefrontal synaptic markers of cocaine addiction-like behavior in rats</article-title><source>Molecular Psychiatry</source><volume>18</volume><fpage>729</fpage><lpage>737</lpage><pub-id pub-id-type="doi">10.1038/mp.2012.59</pub-id><pub-id pub-id-type="pmid">22584869</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kasanetz</surname> <given-names>F</given-names></name><name><surname>Manzoni</surname> <given-names>OJ</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Maturation of excitatory synaptic transmission of the rat nucleus accumbens from juvenile to adult</article-title><source>Journal of Neurophysiology</source><volume>101</volume><fpage>2516</fpage><lpage>2527</lpage><pub-id pub-id-type="doi">10.1152/jn.91039.2008</pub-id><pub-id pub-id-type="pmid">19244354</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kilkenny</surname> <given-names>C</given-names></name><name><surname>Browne</surname> <given-names>WJ</given-names></name><name><surname>Cuthill</surname> <given-names>IC</given-names></name><name><surname>Emerson</surname> <given-names>M</given-names></name><name><surname>Altman</surname> <given-names>DG</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research</article-title><source>PLoS Biology</source><volume>8</volume><elocation-id>e1000412</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.1000412</pub-id><pub-id pub-id-type="pmid">20613859</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ko</surname> <given-names>JY</given-names></name><name><surname>Farr</surname> <given-names>SL</given-names></name><name><surname>Tong</surname> <given-names>VT</given-names></name><name><surname>Creanga</surname> <given-names>AA</given-names></name><name><surname>Callaghan</surname> <given-names>WM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Prevalence and patterns of marijuana use among pregnant and nonpregnant women of reproductive age</article-title><source>American Journal of Obstetrics and Gynecology</source><volume>213</volume><fpage>201.e1</fpage><lpage>20201</lpage><pub-id pub-id-type="doi">10.1016/j.ajog.2015.03.021</pub-id><pub-id pub-id-type="pmid">25772211</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kolb</surname> <given-names>B</given-names></name><name><surname>Mychasiuk</surname> <given-names>R</given-names></name><name><surname>Muhammad</surname> <given-names>A</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Frost</surname> <given-names>DO</given-names></name><name><surname>Gibb</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Experience and the developing prefrontal cortex</article-title><source>PNAS</source><volume>109</volume><fpage>17186</fpage><lpage>17193</lpage><pub-id pub-id-type="doi">10.1073/pnas.1121251109</pub-id><pub-id pub-id-type="pmid">23045653</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kolb</surname> <given-names>B</given-names></name><name><surname>Stewart</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>Sex-related differences in dendritic branching of cells in the prefrontal cortex of rats</article-title><source>Journal of Neuroendocrinology</source><volume>3</volume><fpage>95</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2826.1991.tb00245.x</pub-id><pub-id pub-id-type="pmid">19215453</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Labouesse</surname> <given-names>MA</given-names></name><name><surname>Lassalle</surname> <given-names>O</given-names></name><name><surname>Richetto</surname> <given-names>J</given-names></name><name><surname>Iafrati</surname> <given-names>J</given-names></name><name><surname>Weber-Stadlbauer</surname> <given-names>U</given-names></name><name><surname>Notter</surname> <given-names>T</given-names></name><name><surname>Gschwind</surname> <given-names>T</given-names></name><name><surname>Pujadas</surname> <given-names>L</given-names></name><name><surname>Soriano</surname> <given-names>E</given-names></name><name><surname>Reichelt</surname> <given-names>AC</given-names></name><name><surname>Labouesse</surname> <given-names>C</given-names></name><name><surname>Langhans</surname> <given-names>W</given-names></name><name><surname>Chavis</surname> <given-names>P</given-names></name><name><surname>Meyer</surname> <given-names>U</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Hypervulnerability of the adolescent prefrontal cortex to nutritional stress via reelin deficiency</article-title><source>Molecular Psychiatry</source><volume>22</volume><fpage>961</fpage><lpage>971</lpage><pub-id pub-id-type="doi">10.1038/mp.2016.193</pub-id><pub-id pub-id-type="pmid">27843148</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lafourcade</surname> <given-names>M</given-names></name><name><surname>Elezgarai</surname> <given-names>I</given-names></name><name><surname>Mato</surname> <given-names>S</given-names></name><name><surname>Bakiri</surname> <given-names>Y</given-names></name><name><surname>Grandes</surname> <given-names>P</given-names></name><name><surname>Manzoni</surname> <given-names>OJ</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Molecular components and functions of the endocannabinoid system in mouse prefrontal cortex</article-title><source>PLoS One</source><volume>2</volume><elocation-id>e709</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0000709</pub-id><pub-id pub-id-type="pmid">17684555</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lafourcade</surname> <given-names>M</given-names></name><name><surname>Larrieu</surname> <given-names>T</given-names></name><name><surname>Mato</surname> <given-names>S</given-names></name><name><surname>Duffaud</surname> <given-names>A</given-names></name><name><surname>Sepers</surname> <given-names>M</given-names></name><name><surname>Matias</surname> <given-names>I</given-names></name><name><surname>DeSmedt-Peyrusse</surname> <given-names>v</given-names></name><name><surname>Labrousse</surname> <given-names>VF</given-names></name><name><surname>Bretillon</surname> <given-names>L</given-names></name><name><surname>Matute</surname> <given-names>C</given-names></name><name><surname>Rodríguez-Puertas</surname> <given-names>R</given-names></name><name><surname>Layé</surname> <given-names>S</given-names></name><name><surname>Manzoni</surname> <given-names>OJ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions</article-title><source>Nature Neuroscience</source><volume>14</volume><fpage>345</fpage><lpage>350</lpage><pub-id pub-id-type="doi">10.1038/nn.2736</pub-id><pub-id pub-id-type="pmid">21278728</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larrieu</surname> <given-names>T</given-names></name><name><surname>Madore</surname> <given-names>C</given-names></name><name><surname>Joffre</surname> <given-names>C</given-names></name><name><surname>Layé</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Nutritional n-3 polyunsaturated fatty acids deficiency alters cannabinoid receptor signaling pathway in the brain and associated anxiety-like behavior in mice</article-title><source>Journal of Physiology and Biochemistry</source><volume>68</volume><fpage>671</fpage><lpage>681</lpage><pub-id pub-id-type="doi">10.1007/s13105-012-0179-6</pub-id><pub-id pub-id-type="pmid">22707188</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maccarrone</surname> <given-names>M</given-names></name><name><surname>Guzmán</surname> <given-names>M</given-names></name><name><surname>Mackie</surname> <given-names>K</given-names></name><name><surname>Doherty</surname> <given-names>P</given-names></name><name><surname>Harkany</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Programming of neural cells by (endo)cannabinoids: from physiological rules to emerging therapies</article-title><source>Nature Reviews Neuroscience</source><volume>15</volume><fpage>786</fpage><lpage>801</lpage><pub-id pub-id-type="doi">10.1038/nrn3846</pub-id><pub-id pub-id-type="pmid">25409697</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manduca</surname> <given-names>A</given-names></name><name><surname>Morena</surname> <given-names>M</given-names></name><name><surname>Campolongo</surname> <given-names>P</given-names></name><name><surname>Servadio</surname> <given-names>M</given-names></name><name><surname>Palmery</surname> <given-names>M</given-names></name><name><surname>Trabace</surname> <given-names>L</given-names></name><name><surname>Hill</surname> <given-names>MN</given-names></name><name><surname>Vanderschuren</surname> <given-names>LJ</given-names></name><name><surname>Cuomo</surname> <given-names>V</given-names></name><name><surname>Trezza</surname> <given-names>V</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Distinct roles of the endocannabinoids anandamide and 2-arachidonoylglycerol in social behavior and emotionality at different developmental ages in rats</article-title><source>European Neuropsychopharmacology</source><volume>25</volume><fpage>1362</fpage><lpage>1374</lpage><pub-id pub-id-type="doi">10.1016/j.euroneuro.2015.04.005</pub-id><pub-id pub-id-type="pmid">25914159</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manduca</surname> <given-names>A</given-names></name><name><surname>Lassalle</surname> <given-names>O</given-names></name><name><surname>Sepers</surname> <given-names>M</given-names></name><name><surname>Campolongo</surname> <given-names>P</given-names></name><name><surname>Cuomo</surname> <given-names>V</given-names></name><name><surname>Marsicano</surname> <given-names>G</given-names></name><name><surname>Kieffer</surname> <given-names>B</given-names></name><name><surname>Vanderschuren</surname> <given-names>LJ</given-names></name><name><surname>Trezza</surname> <given-names>V</given-names></name><name><surname>Manzoni</surname> <given-names>OJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Interacting cannabinoid and opioid receptors in the nucleus accumbens core control adolescent social play</article-title><source>Frontiers in Behavioral Neuroscience</source><volume>10</volume><elocation-id>211</elocation-id><pub-id pub-id-type="doi">10.3389/fnbeh.2016.00211</pub-id><pub-id pub-id-type="pmid">27899885</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manduca</surname> <given-names>A</given-names></name><name><surname>Bara</surname> <given-names>A</given-names></name><name><surname>Larrieu</surname> <given-names>T</given-names></name><name><surname>Lassalle</surname> <given-names>O</given-names></name><name><surname>Joffre</surname> <given-names>C</given-names></name><name><surname>Layé</surname> <given-names>S</given-names></name><name><surname>Manzoni</surname> <given-names>OJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Amplification of mGlu<sub>5</sub>-Endocannabinoid signaling rescues behavioral and synaptic feficits in a mouse model of adolescent and adult dietary polyunsaturated fatty acid imbalance</article-title><source>The Journal of Neuroscience</source><volume>37</volume><fpage>6851</fpage><lpage>6868</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3516-16.2017</pub-id><pub-id pub-id-type="pmid">28630250</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maren</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Sexually dimorphic perforant path long-term potentiation (LTP) in urethane-anesthetized rats</article-title><source>Neuroscience Letters</source><volume>196</volume><fpage>177</fpage><lpage>180</lpage><pub-id pub-id-type="doi">10.1016/0304-3940(95)11869-X</pub-id><pub-id pub-id-type="pmid">7501277</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marsicano</surname> <given-names>G</given-names></name><name><surname>Wotjak</surname> <given-names>CT</given-names></name><name><surname>Azad</surname> <given-names>SC</given-names></name><name><surname>Bisogno</surname> <given-names>T</given-names></name><name><surname>Rammes</surname> <given-names>G</given-names></name><name><surname>Cascio</surname> <given-names>MG</given-names></name><name><surname>Hermann</surname> <given-names>H</given-names></name><name><surname>Tang</surname> <given-names>J</given-names></name><name><surname>Hofmann</surname> <given-names>C</given-names></name><name><surname>Zieglgänsberger</surname> <given-names>W</given-names></name><name><surname>Di Marzo</surname> <given-names>V</given-names></name><name><surname>Lutz</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>The endogenous cannabinoid system controls extinction of aversive memories</article-title><source>Nature</source><volume>418</volume><fpage>530</fpage><lpage>534</lpage><pub-id pub-id-type="doi">10.1038/nature00839</pub-id><pub-id pub-id-type="pmid">12152079</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname> <given-names>HG</given-names></name><name><surname>Manzoni</surname> <given-names>OJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Late onset deficits in synaptic plasticity in the valproic acid rat model of autism</article-title><source>Frontiers in Cellular Neuroscience</source><volume>8</volume><elocation-id>23</elocation-id><pub-id pub-id-type="doi">10.3389/fncel.2014.00023</pub-id><pub-id pub-id-type="pmid">24550781</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname> <given-names>HG</given-names></name><name><surname>Bernabeu</surname> <given-names>A</given-names></name><name><surname>Lassalle</surname> <given-names>O</given-names></name><name><surname>Bouille</surname> <given-names>C</given-names></name><name><surname>Beurrier</surname> <given-names>C</given-names></name><name><surname>Pelissier-Alicot</surname> <given-names>AL</given-names></name><name><surname>Manzoni</surname> <given-names>OJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Endocannabinoids mediate muscarinic acetylcholine Receptor-Dependent Long-Term depression in the adult medial prefrontal cortex</article-title><source>Frontiers in Cellular Neuroscience</source><volume>9</volume><elocation-id>457</elocation-id><pub-id pub-id-type="doi">10.3389/fncel.2015.00457</pub-id><pub-id pub-id-type="pmid">26648844</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname> <given-names>HGS</given-names></name><name><surname>Lassalle</surname> <given-names>O</given-names></name><name><surname>Manzoni</surname> <given-names>OJ</given-names></name></person-group><year iso-8601-date="2016">2016a</year><article-title>Differential adulthood onset mGlu 5 signaling saves prefrontal function in the fragile X mouse</article-title><source>Cerebral Cortex</source><volume>27</volume><fpage>5592</fpage><lpage>5602</lpage><pub-id pub-id-type="doi">10.1093/cercor/bhw328</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname> <given-names>HGS</given-names></name><name><surname>Lassalle</surname> <given-names>O</given-names></name><name><surname>Brown</surname> <given-names>JT</given-names></name><name><surname>Manzoni</surname> <given-names>OJ</given-names></name></person-group><year iso-8601-date="2016">2016b</year><article-title>Age-Dependent Long-Term potentiation deficits in the prefrontal cortex of the Fmr1 knockout mouse model of fragile X syndrome</article-title><source>Cerebral Cortex</source><volume>26</volume><fpage>2084</fpage><lpage>2092</lpage><pub-id pub-id-type="doi">10.1093/cercor/bhv031</pub-id><pub-id pub-id-type="pmid">25750254</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname> <given-names>HGS</given-names></name><name><surname>Lassalle</surname> <given-names>O</given-names></name><name><surname>Manzoni</surname> <given-names>OJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Differential adulthood onset mGlu5 signaling saves prefrontal function in the fragile X mouse</article-title><source>Cerebral Cortex</source><volume>27</volume><fpage>5592</fpage><lpage>5602</lpage><pub-id pub-id-type="doi">10.1093/cercor/bhw328</pub-id><pub-id pub-id-type="pmid">27797833</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mateo</surname> <given-names>Y</given-names></name><name><surname>Johnson</surname> <given-names>KA</given-names></name><name><surname>Covey</surname> <given-names>DP</given-names></name><name><surname>Atwood</surname> <given-names>BK</given-names></name><name><surname>Wang</surname> <given-names>HL</given-names></name><name><surname>Zhang</surname> <given-names>S</given-names></name><name><surname>Gildish</surname> <given-names>I</given-names></name><name><surname>Cachope</surname> <given-names>R</given-names></name><name><surname>Bellocchio</surname> <given-names>L</given-names></name><name><surname>Guzmán</surname> <given-names>M</given-names></name><name><surname>Morales</surname> <given-names>M</given-names></name><name><surname>Cheer</surname> <given-names>JF</given-names></name><name><surname>Lovinger</surname> <given-names>DM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Endocannabinoid actions on cortical terminals orchestrate local modulation of dopamine release in the nucleus accumbens</article-title><source>Neuron</source><volume>96</volume><fpage>1112</fpage><lpage>1126</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2017.11.012</pub-id><pub-id pub-id-type="pmid">29216450</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mato</surname> <given-names>S</given-names></name><name><surname>Chevaleyre</surname> <given-names>V</given-names></name><name><surname>Robbe</surname> <given-names>D</given-names></name><name><surname>Pazos</surname> <given-names>A</given-names></name><name><surname>Castillo</surname> <given-names>PE</given-names></name><name><surname>Manzoni</surname> <given-names>OJ</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>A single in-vivo exposure to Delta 9thc blocks endocannabinoid-mediated synaptic plasticity</article-title><source>Nature Neuroscience</source><volume>7</volume><fpage>585</fpage><lpage>586</lpage><pub-id pub-id-type="doi">10.1038/nn1251</pub-id><pub-id pub-id-type="pmid">15146190</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mato</surname> <given-names>S</given-names></name><name><surname>Robbe</surname> <given-names>D</given-names></name><name><surname>Puente</surname> <given-names>N</given-names></name><name><surname>Grandes</surname> <given-names>P</given-names></name><name><surname>Manzoni</surname> <given-names>OJ</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Presynaptic homeostatic plasticity rescues long-term depression after chronic Delta 9-tetrahydrocannabinol exposure</article-title><source>Journal of Neuroscience</source><volume>25</volume><fpage>11619</fpage><lpage>11627</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2294-05.2005</pub-id><pub-id pub-id-type="pmid">16354920</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mereu</surname> <given-names>G</given-names></name><name><surname>Fà</surname> <given-names>M</given-names></name><name><surname>Ferraro</surname> <given-names>L</given-names></name><name><surname>Cagiano</surname> <given-names>R</given-names></name><name><surname>Antonelli</surname> <given-names>T</given-names></name><name><surname>Tattoli</surname> <given-names>M</given-names></name><name><surname>Ghiglieri</surname> <given-names>V</given-names></name><name><surname>Tanganelli</surname> <given-names>S</given-names></name><name><surname>Gessa</surname> <given-names>GL</given-names></name><name><surname>Cuomo</surname> <given-names>V</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Prenatal exposure to a cannabinoid agonist produces memory deficits linked to dysfunction in hippocampal long-term potentiation and glutamate release</article-title><source>PNAS</source><volume>100</volume><fpage>4915</fpage><lpage>4920</lpage><pub-id pub-id-type="doi">10.1073/pnas.0537849100</pub-id><pub-id pub-id-type="pmid">12679519</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moore</surname> <given-names>DG</given-names></name><name><surname>Turner</surname> <given-names>JD</given-names></name><name><surname>Parrott</surname> <given-names>AC</given-names></name><name><surname>Goodwin</surname> <given-names>JE</given-names></name><name><surname>Fulton</surname> <given-names>SE</given-names></name><name><surname>Min</surname> <given-names>MO</given-names></name><name><surname>Fox</surname> <given-names>HC</given-names></name><name><surname>Braddick</surname> <given-names>FM</given-names></name><name><surname>Axelsson</surname> <given-names>EL</given-names></name><name><surname>Lynch</surname> <given-names>S</given-names></name><name><surname>Ribeiro</surname> <given-names>H</given-names></name><name><surname>Frostick</surname> <given-names>CJ</given-names></name><name><surname>Singer</surname> <given-names>LT</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>During pregnancy, recreational drug-using women stop taking ecstasy (3,4-methylenedioxy-N-methylamphetamine) and reduce alcohol consumption, but continue to smoke tobacco and Cannabis: initial findings from the development and infancy study</article-title><source>Journal of Psychopharmacology</source><volume>24</volume><fpage>1403</fpage><lpage>1410</lpage><pub-id pub-id-type="doi">10.1177/0269881109348165</pub-id><pub-id pub-id-type="pmid">19939863</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mulder</surname> <given-names>J</given-names></name><name><surname>Aguado</surname> <given-names>T</given-names></name><name><surname>Keimpema</surname> <given-names>E</given-names></name><name><surname>Barabás</surname> <given-names>K</given-names></name><name><surname>Ballester Rosado</surname> <given-names>CJ</given-names></name><name><surname>Nguyen</surname> <given-names>L</given-names></name><name><surname>Monory</surname> <given-names>K</given-names></name><name><surname>Marsicano</surname> <given-names>G</given-names></name><name><surname>Di Marzo</surname> <given-names>V</given-names></name><name><surname>Hurd</surname> <given-names>YL</given-names></name><name><surname>Guillemot</surname> <given-names>F</given-names></name><name><surname>Mackie</surname> <given-names>K</given-names></name><name><surname>Lutz</surname> <given-names>B</given-names></name><name><surname>Guzmán</surname> <given-names>M</given-names></name><name><surname>Lu</surname> <given-names>HC</given-names></name><name><surname>Galve-Roperh</surname> <given-names>I</given-names></name><name><surname>Harkany</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Endocannabinoid signaling controls pyramidal cell specification and long-range axon patterning</article-title><source>PNAS</source><volume>105</volume><fpage>8760</fpage><lpage>8765</lpage><pub-id pub-id-type="doi">10.1073/pnas.0803545105</pub-id><pub-id pub-id-type="pmid">18562289</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nevian</surname> <given-names>T</given-names></name><name><surname>Sakmann</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Spine Ca2+ signaling in spike-timing-dependent plasticity</article-title><source>Journal of Neuroscience</source><volume>26</volume><fpage>11001</fpage><lpage>11013</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1749-06.2006</pub-id><pub-id pub-id-type="pmid">17065442</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pryce</surname> <given-names>CR</given-names></name><name><surname>Lehmann</surname> <given-names>J</given-names></name><name><surname>Feldon</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Effect of sex on fear conditioning is similar for context and discrete CS in Wistar, Lewis and Fischer rat strains</article-title><source>Pharmacology Biochemistry and Behavior</source><volume>64</volume><fpage>753</fpage><lpage>759</lpage><pub-id pub-id-type="doi">10.1016/S0091-3057(99)00147-1</pub-id><pub-id pub-id-type="pmid">10593198</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puente</surname> <given-names>N</given-names></name><name><surname>Cui</surname> <given-names>Y</given-names></name><name><surname>Lassalle</surname> <given-names>O</given-names></name><name><surname>Lafourcade</surname> <given-names>M</given-names></name><name><surname>Georges</surname> <given-names>F</given-names></name><name><surname>Venance</surname> <given-names>L</given-names></name><name><surname>Grandes</surname> <given-names>P</given-names></name><name><surname>Manzoni</surname> <given-names>OJ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Polymodal activation of the endocannabinoid system in the extended amygdala</article-title><source>Nature Neuroscience</source><volume>14</volume><fpage>1542</fpage><lpage>1547</lpage><pub-id pub-id-type="doi">10.1038/nn.2974</pub-id><pub-id pub-id-type="pmid">22057189</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qi</surname> <given-names>X</given-names></name><name><surname>Zhang</surname> <given-names>K</given-names></name><name><surname>Xu</surname> <given-names>T</given-names></name><name><surname>Yamaki</surname> <given-names>VN</given-names></name><name><surname>Wei</surname> <given-names>Z</given-names></name><name><surname>Huang</surname> <given-names>M</given-names></name><name><surname>Rose</surname> <given-names>GM</given-names></name><name><surname>Cai</surname> <given-names>X</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Sex differences in Long-Term potentiation at Temporoammonic-CA1 synapses: potential implications for memory consolidation</article-title><source>PloS One</source><volume>11</volume><elocation-id>e0165891</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0165891</pub-id><pub-id pub-id-type="pmid">27806108</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ratano</surname> <given-names>P</given-names></name><name><surname>Palmery</surname> <given-names>M</given-names></name><name><surname>Trezza</surname> <given-names>V</given-names></name><name><surname>Campolongo</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Cannabinoid modulation of memory consolidation in rats: beyond the role of cannabinoid receptor subtype 1</article-title><source>Frontiers in Pharmacology</source><volume>8</volume><elocation-id>200</elocation-id><pub-id pub-id-type="doi">10.3389/fphar.2017.00200</pub-id><pub-id pub-id-type="pmid">28446875</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robbe</surname> <given-names>D</given-names></name><name><surname>Kopf</surname> <given-names>M</given-names></name><name><surname>Remaury</surname> <given-names>A</given-names></name><name><surname>Bockaert</surname> <given-names>J</given-names></name><name><surname>Manzoni</surname> <given-names>OJ</given-names></name></person-group><year iso-8601-date="2002">2002a</year><article-title>Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens</article-title><source>PNAS</source><volume>99</volume><fpage>8384</fpage><lpage>8388</lpage><pub-id pub-id-type="doi">10.1073/pnas.122149199</pub-id><pub-id pub-id-type="pmid">12060781</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robbe</surname> <given-names>D</given-names></name><name><surname>Alonso</surname> <given-names>G</given-names></name><name><surname>Chaumont</surname> <given-names>S</given-names></name><name><surname>Bockaert</surname> <given-names>J</given-names></name><name><surname>Manzoni</surname> <given-names>OJ</given-names></name></person-group><year iso-8601-date="2002">2002b</year><article-title>Role of p/q-Ca2+ channels in metabotropic glutamate receptor 2/3-dependent presynaptic long-term depression at nucleus accumbens synapses</article-title><source>The Journal of Neuroscience</source><volume>22</volume><fpage>4346</fpage><lpage>4356</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.22-11-04346.2002</pub-id><pub-id pub-id-type="pmid">12040040</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodríguez de Fonseca</surname> <given-names>F</given-names></name><name><surname>Cebeira</surname> <given-names>M</given-names></name><name><surname>Ramos</surname> <given-names>JA</given-names></name><name><surname>Martín</surname> <given-names>M</given-names></name><name><surname>Fernández-Ruiz</surname> <given-names>JJ</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Cannabinoid receptors in rat brain Areas: sexual differences, fluctuations during estrous cycle and changes after gonadectomy and sex steroid replacement</article-title><source>Life Sciences</source><volume>54</volume><fpage>159</fpage><lpage>170</lpage><pub-id pub-id-type="doi">10.1016/0024-3205(94)00585-0</pub-id><pub-id pub-id-type="pmid">8289577</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rubino</surname> <given-names>T</given-names></name><name><surname>Prini</surname> <given-names>P</given-names></name><name><surname>Piscitelli</surname> <given-names>F</given-names></name><name><surname>Zamberletti</surname> <given-names>E</given-names></name><name><surname>Trusel</surname> <given-names>M</given-names></name><name><surname>Melis</surname> <given-names>M</given-names></name><name><surname>Sagheddu</surname> <given-names>C</given-names></name><name><surname>Ligresti</surname> <given-names>A</given-names></name><name><surname>Tonini</surname> <given-names>R</given-names></name><name><surname>Di Marzo</surname> <given-names>V</given-names></name><name><surname>Parolaro</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Adolescent exposure to THC in female rats disrupts developmental changes in the prefrontal cortex</article-title><source>Neurobiology of Disease</source><volume>73</volume><fpage>60</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1016/j.nbd.2014.09.015</pub-id><pub-id pub-id-type="pmid">25281318</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sciolino</surname> <given-names>NR</given-names></name><name><surname>Zhou</surname> <given-names>W</given-names></name><name><surname>Hohmann</surname> <given-names>AG</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Enhancement of endocannabinoid signaling with JZL184, an inhibitor of the 2-arachidonoylglycerol hydrolyzing enzyme monoacylglycerol lipase, produces anxiolytic effects under conditions of high environmental aversiveness in rats</article-title><source>Pharmacological Research</source><volume>64</volume><fpage>226</fpage><lpage>234</lpage><pub-id pub-id-type="doi">10.1016/j.phrs.2011.04.010</pub-id><pub-id pub-id-type="pmid">21600985</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Segatto</surname> <given-names>M</given-names></name><name><surname>Manduca</surname> <given-names>A</given-names></name><name><surname>Lecis</surname> <given-names>C</given-names></name><name><surname>Rosso</surname> <given-names>P</given-names></name><name><surname>Jozwiak</surname> <given-names>A</given-names></name><name><surname>Swiezewska</surname> <given-names>E</given-names></name><name><surname>Moreno</surname> <given-names>S</given-names></name><name><surname>Trezza</surname> <given-names>V</given-names></name><name><surname>Pallottini</surname> <given-names>V</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Simvastatin treatment highlights a new role for the isoprenoid/cholesterol biosynthetic pathway in the modulation of emotional reactivity and cognitive performance in rats</article-title><source>Neuropsychopharmacology</source><volume>39</volume><fpage>841</fpage><lpage>854</lpage><pub-id pub-id-type="doi">10.1038/npp.2013.284</pub-id><pub-id pub-id-type="pmid">24108067</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomazeau</surname> <given-names>A</given-names></name><name><surname>Lassalle</surname> <given-names>O</given-names></name><name><surname>Iafrati</surname> <given-names>J</given-names></name><name><surname>Souchet</surname> <given-names>B</given-names></name><name><surname>Guedj</surname> <given-names>F</given-names></name><name><surname>Janel</surname> <given-names>N</given-names></name><name><surname>Chavis</surname> <given-names>P</given-names></name><name><surname>Delabar</surname> <given-names>J</given-names></name><name><surname>Manzoni</surname> <given-names>OJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Prefrontal deficits in a murine model overexpressing the down syndrome candidate gene dyrk1a</article-title><source>Journal of Neuroscience</source><volume>34</volume><fpage>1138</fpage><lpage>1147</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2852-13.2014</pub-id><pub-id pub-id-type="pmid">24453307</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomazeau</surname> <given-names>A</given-names></name><name><surname>Bosch-Bouju</surname> <given-names>C</given-names></name><name><surname>Manzoni</surname> <given-names>O</given-names></name><name><surname>Layé</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Nutritional n-3 PUFA deficiency abolishes endocannabinoid gating of hippocampal Long-Term potentiation</article-title><source>Cerebral Cortex</source><volume>27</volume><fpage>2571</fpage><lpage>2579</lpage><pub-id pub-id-type="doi">10.1093/cercor/bhw052</pub-id><pub-id pub-id-type="pmid">26946127</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tortoriello</surname> <given-names>G</given-names></name><name><surname>Morris</surname> <given-names>CV</given-names></name><name><surname>Alpar</surname> <given-names>A</given-names></name><name><surname>Fuzik</surname> <given-names>J</given-names></name><name><surname>Shirran</surname> <given-names>SL</given-names></name><name><surname>Calvigioni</surname> <given-names>D</given-names></name><name><surname>Keimpema</surname> <given-names>E</given-names></name><name><surname>Botting</surname> <given-names>CH</given-names></name><name><surname>Reinecke</surname> <given-names>K</given-names></name><name><surname>Herdegen</surname> <given-names>T</given-names></name><name><surname>Courtney</surname> <given-names>M</given-names></name><name><surname>Hurd</surname> <given-names>YL</given-names></name><name><surname>Harkany</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Miswiring the brain: Δ9-tetrahydrocannabinol disrupts cortical development by inducing an SCG10/stathmin-2 degradation pathway</article-title><source>The EMBO Journal</source><volume>33</volume><fpage>668</fpage><lpage>685</lpage><pub-id pub-id-type="doi">10.1002/embj.201386035</pub-id><pub-id pub-id-type="pmid">24469251</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trezza</surname> <given-names>V</given-names></name><name><surname>Damsteegt</surname> <given-names>R</given-names></name><name><surname>Manduca</surname> <given-names>A</given-names></name><name><surname>Petrosino</surname> <given-names>S</given-names></name><name><surname>Van Kerkhof</surname> <given-names>LW</given-names></name><name><surname>Pasterkamp</surname> <given-names>RJ</given-names></name><name><surname>Zhou</surname> <given-names>Y</given-names></name><name><surname>Campolongo</surname> <given-names>P</given-names></name><name><surname>Cuomo</surname> <given-names>V</given-names></name><name><surname>Di Marzo</surname> <given-names>V</given-names></name><name><surname>Vanderschuren</surname> <given-names>LJ</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Endocannabinoids in amygdala and nucleus accumbens mediate social play reward in adolescent rats</article-title><source>Journal of Neuroscience</source><volume>32</volume><fpage>14899</fpage><lpage>14908</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0114-12.2012</pub-id><pub-id pub-id-type="pmid">23100412</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Kerkhof</surname> <given-names>LW</given-names></name><name><surname>Damsteegt</surname> <given-names>R</given-names></name><name><surname>Trezza</surname> <given-names>V</given-names></name><name><surname>Voorn</surname> <given-names>P</given-names></name><name><surname>Vanderschuren</surname> <given-names>LJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Social play behavior in adolescent rats is mediated by functional activity in medial prefrontal cortex and striatum</article-title><source>Neuropsychopharmacology</source><volume>38</volume><fpage>1899</fpage><lpage>1909</lpage><pub-id pub-id-type="doi">10.1038/npp.2013.83</pub-id><pub-id pub-id-type="pmid">23568326</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vargish</surname> <given-names>GA</given-names></name><name><surname>Pelkey</surname> <given-names>KA</given-names></name><name><surname>Yuan</surname> <given-names>X</given-names></name><name><surname>Chittajallu</surname> <given-names>R</given-names></name><name><surname>Collins</surname> <given-names>D</given-names></name><name><surname>Fang</surname> <given-names>C</given-names></name><name><surname>McBain</surname> <given-names>CJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Persistent inhibitory circuit defects and disrupted social behaviour following in utero exogenous cannabinoid exposure</article-title><source>Molecular Psychiatry</source><volume>22</volume><fpage>56</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1038/mp.2016.17</pub-id><pub-id pub-id-type="pmid">26976041</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="SA1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.36234.024</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Kauer</surname><given-names>Julie A</given-names></name><role>Reviewing Editor</role><aff><institution>Brown University</institution><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Bellone</surname><given-names>Camilla</given-names> </name><role>Reviewer</role><aff><institution>University of Geneva</institution><country>Switzerland</country></aff></contrib><contrib contrib-type="reviewer"><name><surname>Lupica</surname><given-names>Carl</given-names> </name><role>Reviewer</role><aff><institution>NIDA</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.</p></boxed-text><p>Thank you for submitting your article &quot;Sex specific endophenotypes of in-utero cannabinoid exposure&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by a Senior Editor, a Reviewing Editor, and three reviewers. The following individuals involved in review of your submission have agreed to reveal their identity: Camilla Bellone (Reviewer #2); Carl Lupica (Reviewer #3).</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission. In general, all reviewers were enthusiastic about the work, though revision will be required. In particular, the way social interactions were tested requires further information, and may require more experimental evidence. Specific essential revisions are listed below:</p><p>Essential revisions:</p><p>1) The social interactions are tested after 24 hrs of isolation; the authors explain that this isolation period is needed in order to enhance social motivation and to facilitate the social behavior they measure. The social isolation per se could modify social interaction differently between WIN treated and SHAM treated rats, and/or between males and females. The authors should report the results without prior isolation to control for these important possibilities that would change the interpretation of the results.</p><p>2) The authors use the drug SR141716A to block TRPV1 receptors at 5 μM in the slice experiments. This drug has significant effects at TRPV1 receptors, with a reported Ki of around 1 μM (De Petrocellis et al., 2001). In Figure 9B and D, e.g. in which both this drug and capsazepine prevents rescue of LTD or social interaction by the PAM, it is possible that this effect occurs as a result of interactions with both receptors. This interpretation is made less likely by the fact that differential effects of the two drugs at the same in vitro doses are seen in females, but it may still be worth testing a CB1 selective antagonist instead.</p><p>3) The title of the manuscript is a bit cryptic. Maybe something like &quot;Sex-dependent effects of in utero cannabinoid exposure on cortical function&quot; would help sort it out?</p></body></sub-article><sub-article article-type="reply" id="SA2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.36234.025</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1) The social interactions are tested after 24 hrs of isolation; the authors explain that this isolation period is needed in order to enhance social motivation and to facilitate the social behavior they measure. The social isolation per se could modify social interaction differently between WIN treated and SHAM treated rats, and/or between males and females. The authors should report the results without prior isolation to control for these important possibilities that would change the interpretation of the results.</p></disp-quote><p>Our response is twofold:</p><p>1) In our experiments, we tested the animals for social interaction after a brief period of social isolation (24 hours) for the following reasons:</p><p>a) In the social interaction test, the animals are normally singly housed for a short period before the test (File and Seth, 2003). This is a standard and widely accepted procedure, since several independent groups have repeatedly shown that social isolation before testing reliably increases the time spent by the animals in social interaction. As originally standardized by File and Hyde in 1978, the social interaction test used 5 days of individual housing, and Niesink and van Ree (1982) showed that the interaction was maximal after 4–7 days of individual housing. They also reported that the increase in social interactions was not due to a general increase in locomotor or exploratory behavior, since no differences in ambulation between individually- and group-housed animals were observed when they were tested together in the social interaction test (Niesink and van Ree, 1982).</p><p>b) It should be considered that if rats are group-housed and tested for social interaction, sequential removal of the rats from the cage (cohort removal) may act as a rapid and potent stressor for the remaining rats (File and Seth, 2003). To support this possibility, when rats were treated in triads, those removed last position had shorter social interaction time and higher body temperature than those removed first (Kask et al., 2001a).</p><p>c) The deleterious consequences of isolation rearing are usually observed only when animals are isolated for several weeks. However, we agree with the reviewers that even a short isolation period before testing may change the response to drugs. For this reason, we set up a protocol in which animals are isolated for 24 hours only before testing. This period of isolation before testing (that is shorter than in the protocols originally conceived by File and coworkers and van Ree and coworkers and widely accepted worldwide) allows to simultaneously enhance the social motivation of the animals while avoiding cohort removal stress and potential confounding effects due to longer (i.e., several days) isolation housing. Such a protocol has been successfully used in our previous studies.</p><p>2) We also performed the experiments suggested by the reviewers. Thus, a new series of experiments was executed in naïve animals. We did not find sex- or social isolation-depending differences in the total events or time of social interaction (Figure 1—figure supplement 1). Specifically, male and female naïve animals not isolated before testing had similar number of contacts and time spent exploring their congeners than male and female naïve animals isolated 24h before testing (Figure 1—figure supplement 1). Detailed exploration of the various parameters of the social session revealed that the frequency and time of sniffing (Figure 1—figure supplement 1C-D) was unchanged; the play events (i.e. pinning, pouncing and boxing) were reduced in female animals (Figure 1—figure supplement 1E), while the number of attack events remained unchanged (Figure 1—figure supplement 1F).</p><p>In conclusion, although we cannot exclude that in-utero treated animals the 24h isolation period could modify social interaction differently than in naïve animals, the data (response 2 above) and the available literature (response 1 above) do not support this hypothesis.</p><p> <italic>2) The authors use the drug SR141716A to block TRPV1 receptors at 5 μM in the slice experiments. This drug has significant effects at TRPV1 receptors, with a reported Ki of around 1 μM (De Petrocellis et al., 2001). In Figure 9B and D, e.g. in which both this drug and capsazepine prevents rescue of LTD or social interaction by the PAM, it is possible that this effect occurs as a result of interactions with both receptors. This interpretation is made less likely by the fact that differential effects of the two drugs at the same</italic> in vitro <italic>doses are seen in females, but it may still be worth testing a CB1 selective antagonist instead.</italic></p><p>The reviews rightfully raise the important point of SR141716A’ selectivity for CB1R. One could argue that the De Petrocellis’ study, performed in human VR1-overexpressing HEK cells is hard to translate to rat brain slices. However, the paper by Gibson et al., (2008) convincingly shows how in mice hippocampus SR141716A (2µM) can inhibit CB1R and TRPV1R while AM251 (2µM) is more selective for CB1R. As pointed out by the reviewers, taken as a whole, our experiments strongly argue against the possibility that SR141617A blocks prefrontal synaptic plasticity via TRPV1R. Differences in the species (rat vs mice), neuronal types (GABA interneuron, Glutamatergic pyramidal neurons) and brain areas (hippocampus vs prefrontal cortex) may also account for pharmacological differences.</p><p>Thus, beside the CDPPB experiment criticized by the reviewers, the rest of our data clearly show differential effects of SR141716A and capsazepine (a TRPV1R antagonist).</p><p>While we remain convinced that prenatal cannabis has long-term sex specific effects on behavior and synaptic properties, we decided to address experimentally the concerns raised by the reviewers. We have performed a series of new experiments in naïve animals with either the selective CB1 antagonist NESS0327 (1µM, Meye et al., 2013; Lee et al., 2015) and the selective TRPV1R antagonist AMG9810 (3µM, Gavva et al., 2005). As expected from our previous experiments with SR and Capsazepine, the CB1R antagonist NESS0327 prevented LTD induction in naïve rat male but not female slices (Figure 11—figure supplement 1) as observed with SR141716A treatment. In contrast, antagonism of TRPV1R with AMG9810 was without effect in males but prevented the induction of eCB-LTD in naïve females (Figure 11—figure supplement 1).</p><p>The new data confirm that CB1R (not TRPV1R) mediate LTD in adult male while TRPV1R (not CB1R) mediate LTD in adult female rat PFC. They also show that, in our model (adult rat PFC) SR does not seem to antagonize TRPV1R.</p><p>Based on these new data fully displayed in the revised manuscript, we feel that controlling for the selectivity of SR in CDPPB-treated prenatally WIN-exposed male group rather unnecessary.</p><disp-quote content-type="editor-comment"><p>3) The title of the manuscript is a bit cryptic. Maybe something like &quot;Sex-dependent effects of in utero cannabinoid exposure on cortical function&quot; would help sort it out?</p></disp-quote><p>The title has been modified to that suggested by the reviewers.</p></body></sub-article></article>